1
|
Trum M, Schollmeier E, Riechel J, Lebek S, Reuthner K, Keller K, Wester M, Provaznik Z, Schmid C, Maier L, Arzt M, Wagner S. Empagliflozin inhibits increased Na influx in HFpEF cardiomyocytes and reduces arrhythmic activity in human atrial trabeculae. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.2948] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Heart failure with preserved ejection fraction (HFpEF) is a major health problem associated with substantial morbidity and mortality. However, the underlying pathophysiological mechanisms are poorly understood, and effective treatment strategies are scarce. Importantly, SGLT2i, which have been suggested to improve cellular Na and Ca homeostasis in HFrEF, have recently been shown to also improve clinical outcomes in patients with HFpEF. Interestingly, post-hoc analyses of clinical data suggest an involvement of anti-arrhythmic effects of SGLT2i.
Purpose
We tested, if isolated human atrial cardiomyocytes from patients with HFpEF exhibit an increased Na influx that is responsive to treatment with the SGLT2i empagliflozin (Empa) and if Empa has anti-arrhythmic properties in human atrial trabeculae.
Methods
Atrial biopsies were obtained from 101 patients undergoing elective cardiac surgery. Na influx was measured as increase in [Na]i during Na/K-ATPase inhibition in isolated cardiomyocytes loaded with the Na-sensitive fluorescence dye Asante Natrium Green–2 AM (ANG-2). Western Blot and HDAC4 pulldown assay were used to investigate NaV1.5 expression/phosphorylation as well as CaMKII expression/autophosphorylation and activity. Anti-arrhythmic effects of Empa were evaluated as the reduction in premature atrial complexes (PACs), which were induced in electrically field-stimulated (1Hz) human atrial trabeculae by superfusion with isoproterenol (100 nM) and high Ca (3.5 mM).
Results
Compared to patients without heart failure (NF), Na influx was almost doubled in HFpEF patients (NF vs HFpEF: 0.21±0.02 vs 0.38±0.04 mmol/L/min (N=7 vs 18); p=0.005) (Fig. 1D, E). CaMKII expression, CaMKII autophosphorylation, CaMKII activity, and CaMKII-dependent NaV1.5 phosphorylation were significantly increased in atrial biopsies of HFpEF patients, whereas NaV1.5 protein abundance remained unchanged (Fig. 1A–C). Consistent with these results, the increased Na influx was significantly reduced by treatment with the specific CaMKII inhibitor autocamtide-2 related inhibitory peptide (AIP) and the late INa inhibitor tetrodotoxin (TTX) (Fig. 1D, E). Importantly, Empa also abolished the increased Na influx in HFpEF cardiomyocytes (Fig. 1D, E). Multivariate linear regression analysis, adjusting for clinical co-variates, revealed HFpEF to be an independent predictor of cardiomyocyte Na handling. In line with Empa-mediated inhibition of Na influx, the frequency of PACs in human atrial trabeculae was significantly reduced by Empa (Fig. 1F, G).
Conclusion
This is the first study to demonstrate increased Na influx in human cardiomyocytes from HFpEF patients potentially by an increased CaMKII-dependent NaV1.5 phosphorylation. Excitingly, treatment with Empa decreases this Na influx in HFpEF cardiomyocytes and reduces isoproterenol-induced arrhythmic activity in human atrial trabeculae, which could contribute to the cardioprotective effects of this drug in patients with HFpEF.
Funding Acknowledgement
Type of funding sources: Public Institution(s). Main funding source(s): Else Kröner-Fresenius-Stiftung,Deutsche Forschungsgemeinschaft
Collapse
Affiliation(s)
- M Trum
- University Hospital Regensburg, Internal Medicine II , Regensburg , Germany
| | - E Schollmeier
- University Hospital Regensburg, Internal Medicine II , Regensburg , Germany
| | - J Riechel
- University Hospital Regensburg, Internal Medicine II , Regensburg , Germany
| | - S Lebek
- University Hospital Regensburg, Internal Medicine II , Regensburg , Germany
| | - K Reuthner
- University Hospital Regensburg, Internal Medicine II , Regensburg , Germany
| | - K Keller
- Hospital Barmherzige Bruder , Regensburg , Germany
| | - M Wester
- University Hospital Regensburg, Internal Medicine II , Regensburg , Germany
| | - Z Provaznik
- University Hospital Regensburg, Cardiothoracic Surgery , Regensburg , Germany
| | - C Schmid
- University Hospital Regensburg, Cardiothoracic Surgery , Regensburg , Germany
| | - L Maier
- University Hospital Regensburg, Internal Medicine II , Regensburg , Germany
| | - M Arzt
- University Hospital Regensburg, Internal Medicine II , Regensburg , Germany
| | - S Wagner
- University Hospital Regensburg, Internal Medicine II , Regensburg , Germany
| |
Collapse
|
2
|
Pabel S, Knierim M, Stehle T, Poeppl A, Hasenfuss G, Maier L, Streckfuss-Boemeke K, Sossalla S. Electrophysiological remodeling in tachycardia-induced cardiomyopathy. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.2889] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Tachycardia-induced cardiomyopathy (TCM) is a reversible and likely underrecognized form of heart failure. Thus, a better understanding of the TCM-pathophysiology is warranted as the underlying early mechanisms that mediate the progression of TCM remain unclear.
Purpose
This study aimed to identify the cellular mechanisms of TCM.
Methods and results
Human induced pluripotent stem cell cardiomyocytes (iPSC-CM) were utilized as a translational human-based model. We performed chronic tachycardic (120 bpm) or normofrequent (control, 60bpm) cell culture pacing to study cellular changes during TCM progression.
Already after 24h of tachycardic stimulation of iPSC-CM, we detected a decrease in Ca transient amplitude compared to control (Fura-2, n=49/44 cells/9 differentiations). Diastolic Ca levels and cytosolic Ca elimination were not affected after 24h of tachycardia (n=49/44/9). We detected no difference in sarcoplasmic reticulum (SR) Ca load (assessed via caffeine application) or SERCA activity (Ksys-Kcaff) after 24h of tachycardia (n=13/15/5). However, demonstrating the progress of TCM, 7d of tachycardia resulted in progressive decline of Ca transient amplitude together with an impaired Ca elimination, while diastolic Ca concentration was unchanged (n=73/66/8). These changes may underlie the reduced systolic force and impaired relaxation in TCM. We could explain these results by a significantly reduced SR Ca load and a diminished SERCA activity after 7d tachycardia (n=13/7 vs. 13/4). Using confocal microscopy (Fluo-4) we detected no difference in SR Ca spark frequency after 24h of tachycardia (n=82/66/8), while 7d of tachycardia caused an increase of Ca spark frequency (n=76/79/7), which is a typical hallmark of maladaptive remodeling in HF and likely underlie the reduced SR Ca load. Voltage clamp data of late Na current (INaL) showed no difference in INaL after 24h of stimulation (n=17/6 vs. 19/7), whereas INaL was increased after 7d of tachycardia (n=26/7 vs. 19/6). Accordingly, whole-cell current clamp experiments revealed a prolongation of the action potential after 7d of tachycardia compared to control (n=21/6 vs. 19/5), while no difference of action potential duration could be detected after 24h (n=37/31/8). Resting membrane potential and action potential amplitude were not changed. Finally, we investigated tachycardia-mediated effects on explanted human failing hearts. 8h of tachycardic stimulation (120 bpm) of human failing ventricular trabeculae already compromised systolic force, and diastolic tension and relaxation time were markedly increased compared to control (60bpm, n=8/6 trabeculae /7/6 human hearts).
Conclusion
This study demonstrates that persistent tachycardia adversely alters cardiomyocyte excitation-contraction coupling via electrophysiological cellular remodeling. Our translational investigation in human myocardium may help to understand the pathophysiology of an underrated but prevalent disease.
Funding Acknowledgement
Type of funding sources: Foundation. Main funding source(s): Else Kröner-Fresenius-Stiftung (EKFS)Deutsche Gesellschaft für Innere Medizin
Collapse
Affiliation(s)
- S Pabel
- University Hospital Regensburg , Regensburg , Germany
| | - M Knierim
- University Medical Center Gottingen (UMG), Dept. of Cardiology and Pneumology, Heart Center , Gottingen , Germany
| | - T Stehle
- University Hospital Regensburg , Regensburg , Germany
| | - A Poeppl
- University Hospital Regensburg , Regensburg , Germany
| | - G Hasenfuss
- University Medical Center Gottingen (UMG), Dept. of Cardiology and Pneumology, Heart Center , Gottingen , Germany
| | - L Maier
- University Hospital Regensburg , Regensburg , Germany
| | - K Streckfuss-Boemeke
- University Hospital of Wurzburg, Institute of Pharmacology and Toxicology , Würzburg , Germany
| | - S Sossalla
- University Hospital Regensburg , Regensburg , Germany
| |
Collapse
|
3
|
Serban KA, Pratte KA, Strange C, Sandhaus RA, Turner AM, Beiko T, Spittle DA, Maier L, Hamzeh N, Silverman EK, Hobbs BD, Hersh CP, DeMeo DL, Cho MH, Bowler RP. Unique and shared systemic biomarkers for emphysema in Alpha-1 Antitrypsin deficiency and chronic obstructive pulmonary disease. EBioMedicine 2022; 84:104262. [PMID: 36155958 PMCID: PMC9507992 DOI: 10.1016/j.ebiom.2022.104262] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2022] [Revised: 08/02/2022] [Accepted: 08/23/2022] [Indexed: 11/22/2022] Open
Abstract
BACKGROUND Alpha-1 Antitrypsin (AAT) deficiency (AATD), the most common genetic cause of emphysema presents with unexplained phenotypic heterogeneity in affected subjects. Our objectives to identify unique and shared AATD plasma biomarkers with chronic obstructive pulmonary disease (COPD) may explain AATD phenotypic heterogeneity. METHODS The plasma or serum of 5,924 subjects from four AATD and COPD cohorts were analyzed on SomaScan V4.0 platform. Using multivariable linear regression, inverse variance random-effects meta-analysis, and Least Absolute Shrinkage and Selection Operator (LASSO) regression we tested the association between 4,720 individual proteins or combined in a protein score with emphysema measured by 15th percentile lung density (PD15) or diffusion capacity (DLCO) in distinct AATD genotypes (Pi*ZZ, Pi*SZ, Pi*MZ) and non-AATD, PiMM COPD subjects. AAT SOMAmer accuracy for identifying AATD was tested using receiver operating characteristic curve analysis. FINDINGS In PiZZ AATD subjects, 2 unique proteins were associated with PD15 and 98 proteins with DLCO. Of those, 68 were also associated with DLCO in COPD also and enriched for three cellular component pathways: insulin-like growth factor, lipid droplet, and myosin complex. PiMZ AATD subjects shared similar proteins associated with DLCO as COPD subjects. Our emphysema protein score included 262 SOMAmers and predicted emphysema in AATD and COPD subjects. SOMAmer AAT level <7.99 relative fluorescence unit (RFU) had 100% sensitivity and specificity for identifying Pi*ZZ, but it was lower for other AATD genotypes. INTERPRETATION Using SomaScan, we identified unique and shared plasma biomarkers between AATD and COPD subjects and generated a protein score that strongly associates with emphysema in COPD and AATD. Furthermore, we discovered unique biomarkers associated with DLCO and emphysema in PiZZ AATD. FUNDING This work was supported by a grant from the Alpha-1 Foundation to RPB. COPDGene was supported by Award U01 HL089897 and U01 HL089856 from the National Heart, Lung, and Blood Institute. Proteomics for COPDGene was supported by NIH 1R01HL137995. GRADS was supported by Award U01HL112707, U01 HL112695 from the National Heart, Lung, and Blood Institute, and UL1TRR002535 to CCTSI; QUANTUM-1 was supported by the National Heart Lung and Blood Institute, the Office of Rare Diseases through the Rare Lung Disease Clinical Research Network (1 U54 RR019498-01, Trapnell PI), and the Alpha-1 Foundation. COPDGene is also supported by the COPD Foundation through contributions made to an Industry Advisory Board that has included AstraZeneca, Bayer Pharmaceuticals, Boehringer-Ingelheim, Genentech, GlaxoSmithKline, Novartis, Pfizer, and Sunovion.
Collapse
Affiliation(s)
- K A Serban
- Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, National Jewish Health, Denver, CO, United States; Department of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Aurora, CO, United States.
| | - K A Pratte
- Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, National Jewish Health, Denver, CO, United States
| | - C Strange
- Pulmonary, Critical Care, Allergy and Sleep Medicine, Medical University of South Carolina, Charleston, SC, United States
| | - R A Sandhaus
- Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, National Jewish Health, Denver, CO, United States
| | - A M Turner
- Institute for Applied Health Research, University of Birmingham, Birmingham, UK
| | - T Beiko
- Pulmonary, Critical Care, Allergy and Sleep Medicine, Medical University of South Carolina, Charleston, SC, United States
| | - D A Spittle
- Institute of Inflammation and Aging, University of Birmingham, UK
| | - L Maier
- Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, National Jewish Health, Denver, CO, United States; Department of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Aurora, CO, United States
| | - N Hamzeh
- Pulmonary, Critical Care, Allergy and Sleep Medicine, University of Iowa, Iowa City, IA, United States
| | - E K Silverman
- Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States
| | - B D Hobbs
- Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States
| | - C P Hersh
- Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States
| | - D L DeMeo
- Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States
| | - M H Cho
- Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States
| | - R P Bowler
- Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, National Jewish Health, Denver, CO, United States; Department of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Aurora, CO, United States.
| |
Collapse
|
4
|
Jaensch M, Trum M, Williams T, Schmitt J, Schuh K, Qadri F, Maier L, Bader M, Ritter O. Investigations regarding the role of NOS1AP in the heart using a conditional overexpression mouse model. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.3217] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Background
35.3% of deaths in 2019 in Germany are caused by cardiovascular diseases (Destatis). 95% of these people were 60 years and older. To increase survival rate in elderly patients we investigate the relevance of altered expression of neuronal nitric oxide synthase 1 (NOS1) adaptor protein (NOS1AP) acting as an L-type calcium channel (CaV1.2) modulator via directing NOS1 to CaV1.2 on cardiac electrophysiology. Genome-wide association studies have linked genetic polymorphisms in NOS1AP to variations in QT interval duration (QTc). The QT interval reflects ventricular de- and repolarization. It may predispose individuals to ventricular tachycardia and sudden cardiac death (SCD) if prolonged, shortened or otherwise unregularly. In addition, about 20% of families with a clinically proven diagnosis of long QT syndrome (LQTS) host no mutation in any of the 16 associated genes.
Methods and results
Transgenic mice with conditional overexpression of NOS1AP in cardiac myocytes were used as model organism. We confirmed the interaction of NOS1AP with NOS1 and CaV1.2. Electrocardiography in NOS1AP overexpressing mice showed atrial and ventricular tachycardia both spontaneously and upon programmed stimulation associated with a significant decrease in QTc. Heart rates in NOS1AP overexpressing mice were similar to non-induced animals. Survival was significantly reduced (only 60% after 12 weeks vs. 100% in non-induced mice). Induced QTc alterations and accompanied deaths subsided upon re-administration of doxycycline.
Whole-cell patch-clamp measurements in isolated adult ventricular myocytes were performed and action potential duration at 90% of repolarization (APD90) was significantly reduced in induced transgenic NOS1AP overexpressing mice compared to control littermates.
In addition, we investigated the functional effect of the human SNP rs16847548 (T/C) located within the NOS1AP promoter. The SNP was found to decrease the transcriptional activity of NOS1AP in vitro and therefore, potentially leading to a decrease in NOS1AP expression in humans.
Conclusion
Myocardial overexpression of NOS1AP leads to short QT syndrome with increased susceptibility to atrial and ventricular arrhythmias and cardiac death. In accordance, APD90 is significantly shortened in overexpressing animals. The human SNP rs16847548, which is located in the promoter region of NOS1AP, results in a reduced NOS1AP promoter activity in vitro, hereby providing an explanation for the frequently published elongation of QT intervals. In summary, not only mutations in ion channels themselves but also genetic alterations in the expression of ion channel modulators such as NOS1AP, have an impact on QTc and arrhythmogenesis and represent a promising therapeutic target for LQTS patients.
Funding Acknowledgement
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Gesundheitscampus Brandenburg (MWFK)
Collapse
Affiliation(s)
- M Jaensch
- University Hospital Brandenburg, Department of Internal Medicine I, Brandenburg an der Havel, Germany
| | - M Trum
- University Hospital Regensburg, Department of Internal Medicine II, Regensburg, Germany
| | - T Williams
- University Hospital Würzburg, Comprehensive Heart Failure Center and Department of Internal Medicine I, Wuerzburg, Germany
| | - J Schmitt
- Heinrich Heine University, Department of Pharmacology and Clinical Pharmacology, Duesseldorf, Germany
| | - K Schuh
- University of Wuerzburg, Institute of Physiology, Wuerzburg, Germany
| | - F Qadri
- Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Molecular Biology of Peptide Hormones, Berlin, Germany
| | - L Maier
- University Hospital Regensburg, Department of Internal Medicine II, Regensburg, Germany
| | - M Bader
- Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Molecular Biology of Peptide Hormones, Berlin, Germany
| | - O Ritter
- University Hospital Brandenburg, Department of Internal Medicine I, Brandenburg an der Havel, Germany
| |
Collapse
|
5
|
Pabel S, Knierim M, Stehle T, Alebrand F, Paulus M, Sieme M, Herwig M, Sedej S, Scherr D, Brochhausen C, Hasenfuss G, Maier L, Hamdani N, Streckfuss-Boemeke K, Sossalla S. Effects of atrial fibrillation on ventricular remodeling in the human heart. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.3216] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Atrial fibrillation (AF) is often found in patients with heart failure (HF). Clinical data indicated that the arrhythmic component of AF alone could contribute to left-ventricular (LV) dysfunction. However, the effects of non-tachycardic AF with arrhythmic excitation of the human LV, are unknown.
We investigated human LV myocardium from patients with sinus rhythm (SR) or normofrequent AF (mean EF>50%, matched clinical data, derived from septal resections during AVR). In histological analysis we detected no difference between SR (n=17 patients) and AF patients (n=18) regarding the amount and distribution of fibrosis. We isolated human LV cardiomyocytes (CM) and studied cellular Ca-handling (Fura-2). Systolic Ca-transient amplitude of LV CM was reduced in patients suffering from AF (n=8 AF patients vs. 11 SR), while diastolic Ca-levels and Ca-transient kinetics were not significantly changed. These results were confirmed in LV CM from non-failing donors (NF) with AF (n=4 AF patients vs. 8 SR). For the standardized investigation of a normofrequent arrhythmia, we simulated AF in vitro by using arrhythmic (60 bpm, 40% beat-to-beat variability) or rhythmic (60 bpm) field stimulation. Human LV CM from NF SR patients (n=8) showed an impaired Ca-transient amplitude after 24h arrhythmic culture pacing without changes in diastolic Ca and Ca-transient kinetics. For studying a model suitable for more standardized chronic pacing, we utilized human iPSC cardiomyocytes (iPSC-CM) from healthy donors (n=6). After 7 days, arrhythmically paced iPSC-CM exhibited a reduced systolic Ca-transient amplitude, a trend towards a prolonged Ca-elimination time and a reduced sarcoplasmic reticulum Ca-load. Confocal line-scans of arrhythmically paced cells (Fluo-4 AM) showed an increased diastolic Ca-leak from the sarcoplasmic reticulum, possibly underlying the reduced Ca-load. Coupled with the Ca changes, cytosolic Na was elevated after arrhythmia. We found an increased late INa, which could explain the detrimentally altered Ca/Na-interplay. Accordingly, Patch-clamp experiments revealed a prolonged action potential duration after arrhythmia. We further elucidated the underlying mechanisms of this electrophysiological remodeling by showing that oxidative stress (H2O2, LPO) is increased in the LV of patients suffering from AF (n=6 AF patients vs. 6 SR), which was associated with an enhanced NOX2/-4 activity. Consecutively, Ca2+/calmodulin-dependent protein kinase IIδ (CaMKII) was found to be more oxidized (CaMKII-Met281/282) in the LV of AF patients (n=7 AF patients vs. 7 SR) leading to an increased CaMKII activity, which adversely regulated EC-coupling protein phosphorylation including RyR2 hyperphosphorylation.
Normofrequent arrhythmia/AF impairs human ventricular EC-coupling via increased oxidative stress and enhanced CaMKII. Thus, this translational study provides the first mechanistic characterization and the potential negative impact of isolated AF on the human LV.
Funding Acknowledgement
Type of funding sources: Public Institution(s). Main funding source(s): Else Kröner-Fresenius-Stiftung (EKFS) and Deutsche Gesellschaft für Innere Medizin
Collapse
Affiliation(s)
- S Pabel
- University hospital Regensburg, Regensburg, Germany
| | - M Knierim
- University Medical Center Gottingen (UMG), Dept. of Cardiology and Pneumology, Heart Center, Gottingen, Germany
| | - T Stehle
- University hospital Regensburg, Regensburg, Germany
| | - F Alebrand
- University Medical Center Gottingen (UMG), Dept. of Cardiology and Pneumology, Heart Center, Gottingen, Germany
| | - M Paulus
- University hospital Regensburg, Regensburg, Germany
| | - M Sieme
- Ruhr University Bochum, Department of Molecular and Experimental Cardiology, Bochum, Germany
| | - M Herwig
- Ruhr University Bochum, Department of Molecular and Experimental Cardiology, Bochum, Germany
| | - S Sedej
- University Hospital Graz, Department of Cardiology, Graz, Austria
| | - D Scherr
- University Hospital Graz, Department of Cardiology, Graz, Austria
| | - C Brochhausen
- University of Regensburg, Institute of Pathology, Regensburg, Germany
| | - G Hasenfuss
- University Medical Center Gottingen (UMG), Dept. of Cardiology and Pneumology, Heart Center, Gottingen, Germany
| | - L Maier
- University hospital Regensburg, Regensburg, Germany
| | - N Hamdani
- Ruhr University Bochum, Department of Molecular and Experimental Cardiology, Bochum, Germany
| | - K Streckfuss-Boemeke
- University Medical Center Gottingen (UMG), Dept. of Cardiology and Pneumology, Heart Center, Gottingen, Germany
| | - S Sossalla
- University hospital Regensburg, Regensburg, Germany
| |
Collapse
|
6
|
Adamczewski-Musch J, Arnold O, Behnke C, Belounnas A, Belyaev A, Berger-Chen JC, Blanco A, Blume C, Böhmer M, Bordalo P, Chernenko S, Chlad L, Ciepal I, Deveaux C, Dreyer J, Epple E, Fabbietti L, Fateev O, Filip P, Fonte P, Franco C, Friese J, Fröhlich I, Galatyuk T, Garzón JA, Gernhäuser R, Golosov O, Golubeva M, Greifenhagen R, Guber F, Gumberidze M, Harabasz S, Heinz T, Hennino T, Hlavac S, Höhne C, Holzmann R, Ierusalimov A, Ivashkin A, Kämpfer B, Karavicheva T, Kardan B, Koenig I, Koenig W, Kohls M, Kolb BW, Korcyl G, Kornakov G, Kornas F, Kotte R, Kugler A, Kunz T, Kurepin A, Kurilkin A, Kurilkin P, Ladygin V, Lalik R, Lapidus K, Lebedev A, Lopes L, Lorenz M, Mahmoud T, Maier L, Malige A, Mamaev M, Mangiarotti A, Markert J, Matulewicz T, Maurus S, Metag V, Michel J, Mihaylov DM, Morozov S, Müntz C, Münzer R, Naumann L, Nowakowski K, Parpottas Y, Pechenov V, Pechenova O, Petukhov O, Piasecki K, Pietraszko J, Przygoda W, Pysz K, Ramos S, Ramstein B, Rathod N, Reshetin A, Rodriguez-Ramos P, Rosier P, Rost A, Rustamov A, Sadovsky A, Salabura P, Scheib T, Schuldes H, Schwab E, Scozzi F, Seck F, Sellheim P, Selyuzhenkov I, Siebenson J, Silva L, Singh U, Smyrski J, Sobolev YG, Spataro S, Spies S, Ströbele H, Stroth J, Sturm C, Svoboda O, Szala M, Tlusty P, Traxler M, Tsertos H, Usenko E, Wagner V, Wendisch C, Wiebusch MG, Wirth J, Wójcik D, Zanevsky Y, Zumbruch P. Directed, Elliptic, and Higher Order Flow Harmonics of Protons, Deuterons, and Tritons in Au+Au Collisions at sqrt[s_{NN}]=2.4 GeV. Phys Rev Lett 2020; 125:262301. [PMID: 33449792 DOI: 10.1103/physrevlett.125.262301] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/26/2020] [Revised: 10/07/2020] [Accepted: 11/29/2020] [Indexed: 06/12/2023]
Abstract
Flow coefficients v_{n} of the orders n=1-6 are measured with the High-Acceptance DiElectron Spectrometer (HADES) at GSI for protons, deuterons, and tritons as a function of centrality, transverse momentum, and rapidity in Au+Au collisions at sqrt[s_{NN}]=2.4 GeV. Combining the information from the flow coefficients of all orders allows us to construct for the first time, at collision energies of a few GeV, a multidifferential picture of the angular emission pattern of these particles. It reflects the complicated interplay between the effect of the central fireball pressure on the emission of particles and their subsequent interaction with spectator matter. The high precision information on higher order flow coefficients is a major step forward in constraining the equation of state of dense baryonic matter.
Collapse
Affiliation(s)
- J Adamczewski-Musch
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - O Arnold
- Excellence Cluster "Origin and Structure of the Universe," 85748 Garching, Germany
- Physik Department E62, Technische Universität München, 85748 Garching, Germany
| | - C Behnke
- Institut für Kernphysik, Goethe-Universität, 60438 Frankfurt, Germany
| | - A Belounnas
- Laboratoire de Physique des 2 infinis Irène Joliot-Curie, Université Paris-Saclay, CNRS-IN2P3, F-91405 Orsay, France
| | - A Belyaev
- Joint Institute of Nuclear Research, 141980 Dubna, Russia
| | - J C Berger-Chen
- Excellence Cluster "Origin and Structure of the Universe," 85748 Garching, Germany
- Physik Department E62, Technische Universität München, 85748 Garching, Germany
| | - A Blanco
- LIP-Laboratório de Instrumentação e Física Experimental de Partículas, 3004-516 Coimbra, Portugal
| | - C Blume
- Institut für Kernphysik, Goethe-Universität, 60438 Frankfurt, Germany
| | - M Böhmer
- Physik Department E62, Technische Universität München, 85748 Garching, Germany
| | - P Bordalo
- LIP-Laboratório de Instrumentação e Física Experimental de Partículas, 3004-516 Coimbra, Portugal
| | - S Chernenko
- Joint Institute of Nuclear Research, 141980 Dubna, Russia
| | - L Chlad
- Nuclear Physics Institute, The Czech Academy of Sciences, 25068 Rez, Czech Republic
| | - I Ciepal
- Institute of Nuclear Physics, Polish Academy of Sciences, 31342 Kraków, Poland
| | - C Deveaux
- II.Physikalisches Institut, Justus Liebig Universität Giessen, 35392 Giessen, Germany
| | - J Dreyer
- Institut für Strahlenphysik, Helmholtz-Zentrum Dresden-Rossendorf, 01314 Dresden, Germany
| | - E Epple
- Excellence Cluster "Origin and Structure of the Universe," 85748 Garching, Germany
- Physik Department E62, Technische Universität München, 85748 Garching, Germany
| | - L Fabbietti
- Excellence Cluster "Origin and Structure of the Universe," 85748 Garching, Germany
- Physik Department E62, Technische Universität München, 85748 Garching, Germany
| | - O Fateev
- Joint Institute of Nuclear Research, 141980 Dubna, Russia
| | - P Filip
- Institute of Physics, Slovak Academy of Sciences, 84228 Bratislava, Slovakia
| | - P Fonte
- LIP-Laboratório de Instrumentação e Física Experimental de Partículas, 3004-516 Coimbra, Portugal
| | - C Franco
- LIP-Laboratório de Instrumentação e Física Experimental de Partículas, 3004-516 Coimbra, Portugal
| | - J Friese
- Physik Department E62, Technische Universität München, 85748 Garching, Germany
| | - I Fröhlich
- Institut für Kernphysik, Goethe-Universität, 60438 Frankfurt, Germany
| | - T Galatyuk
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
- Technische Universität Darmstadt, 64289 Darmstadt, Germany
| | - J A Garzón
- LabCAF. F. Física, Universidad de Santiago de Compostela, 15706 Santiago de Compostela, Spain
| | - R Gernhäuser
- Physik Department E62, Technische Universität München, 85748 Garching, Germany
| | - O Golosov
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia
| | - M Golubeva
- Institute for Nuclear Research, Russian Academy of Science, 117312 Moscow, Russia
| | - R Greifenhagen
- Institut für Strahlenphysik, Helmholtz-Zentrum Dresden-Rossendorf, 01314 Dresden, Germany
| | - F Guber
- Institute for Nuclear Research, Russian Academy of Science, 117312 Moscow, Russia
| | - M Gumberidze
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
- Technische Universität Darmstadt, 64289 Darmstadt, Germany
| | - S Harabasz
- Smoluchowski Institute of Physics, Jagiellonian University of Cracow, 30-059 Kraków, Poland
- Technische Universität Darmstadt, 64289 Darmstadt, Germany
| | - T Heinz
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - T Hennino
- Laboratoire de Physique des 2 infinis Irène Joliot-Curie, Université Paris-Saclay, CNRS-IN2P3, F-91405 Orsay, France
| | - S Hlavac
- Institute of Physics, Slovak Academy of Sciences, 84228 Bratislava, Slovakia
| | - C Höhne
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
- II.Physikalisches Institut, Justus Liebig Universität Giessen, 35392 Giessen, Germany
| | - R Holzmann
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - A Ierusalimov
- Joint Institute of Nuclear Research, 141980 Dubna, Russia
| | - A Ivashkin
- Institute for Nuclear Research, Russian Academy of Science, 117312 Moscow, Russia
| | - B Kämpfer
- Institut für Strahlenphysik, Helmholtz-Zentrum Dresden-Rossendorf, 01314 Dresden, Germany
| | - T Karavicheva
- Institute for Nuclear Research, Russian Academy of Science, 117312 Moscow, Russia
| | - B Kardan
- Institut für Kernphysik, Goethe-Universität, 60438 Frankfurt, Germany
| | - I Koenig
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - W Koenig
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - M Kohls
- Institut für Kernphysik, Goethe-Universität, 60438 Frankfurt, Germany
| | - B W Kolb
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - G Korcyl
- Smoluchowski Institute of Physics, Jagiellonian University of Cracow, 30-059 Kraków, Poland
| | - G Kornakov
- Technische Universität Darmstadt, 64289 Darmstadt, Germany
| | - F Kornas
- Technische Universität Darmstadt, 64289 Darmstadt, Germany
| | - R Kotte
- Institut für Strahlenphysik, Helmholtz-Zentrum Dresden-Rossendorf, 01314 Dresden, Germany
| | - A Kugler
- Nuclear Physics Institute, The Czech Academy of Sciences, 25068 Rez, Czech Republic
| | - T Kunz
- Physik Department E62, Technische Universität München, 85748 Garching, Germany
| | - A Kurepin
- Institute for Nuclear Research, Russian Academy of Science, 117312 Moscow, Russia
| | - A Kurilkin
- Joint Institute of Nuclear Research, 141980 Dubna, Russia
| | - P Kurilkin
- Joint Institute of Nuclear Research, 141980 Dubna, Russia
| | - V Ladygin
- Joint Institute of Nuclear Research, 141980 Dubna, Russia
| | - R Lalik
- Smoluchowski Institute of Physics, Jagiellonian University of Cracow, 30-059 Kraków, Poland
| | - K Lapidus
- Excellence Cluster "Origin and Structure of the Universe," 85748 Garching, Germany
- Physik Department E62, Technische Universität München, 85748 Garching, Germany
| | - A Lebedev
- Institute of Theoretical and Experimental Physics, 117218 Moscow, Russia
| | - L Lopes
- LIP-Laboratório de Instrumentação e Física Experimental de Partículas, 3004-516 Coimbra, Portugal
| | - M Lorenz
- Institut für Kernphysik, Goethe-Universität, 60438 Frankfurt, Germany
| | - T Mahmoud
- II.Physikalisches Institut, Justus Liebig Universität Giessen, 35392 Giessen, Germany
| | - L Maier
- Physik Department E62, Technische Universität München, 85748 Garching, Germany
| | - A Malige
- Smoluchowski Institute of Physics, Jagiellonian University of Cracow, 30-059 Kraków, Poland
| | - M Mamaev
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia
| | - A Mangiarotti
- LIP-Laboratório de Instrumentação e Física Experimental de Partículas, 3004-516 Coimbra, Portugal
| | - J Markert
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - T Matulewicz
- Uniwersytet Warszawski, Wydział Fizyki, Instytut Fizyki Doświadczalnej, 02-093 Warszawa, Poland
| | - S Maurus
- Physik Department E62, Technische Universität München, 85748 Garching, Germany
| | - V Metag
- II.Physikalisches Institut, Justus Liebig Universität Giessen, 35392 Giessen, Germany
| | - J Michel
- Institut für Kernphysik, Goethe-Universität, 60438 Frankfurt, Germany
| | - D M Mihaylov
- Excellence Cluster "Origin and Structure of the Universe," 85748 Garching, Germany
- Physik Department E62, Technische Universität München, 85748 Garching, Germany
| | - S Morozov
- Institute for Nuclear Research, Russian Academy of Science, 117312 Moscow, Russia
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia
| | - C Müntz
- Institut für Kernphysik, Goethe-Universität, 60438 Frankfurt, Germany
| | - R Münzer
- Excellence Cluster "Origin and Structure of the Universe," 85748 Garching, Germany
- Physik Department E62, Technische Universität München, 85748 Garching, Germany
| | - L Naumann
- Institut für Strahlenphysik, Helmholtz-Zentrum Dresden-Rossendorf, 01314 Dresden, Germany
| | - K Nowakowski
- Smoluchowski Institute of Physics, Jagiellonian University of Cracow, 30-059 Kraków, Poland
| | - Y Parpottas
- Department of Physics, University of Cyprus, 1678 Nicosia, Cyprus
| | - V Pechenov
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - O Pechenova
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - O Petukhov
- Institute for Nuclear Research, Russian Academy of Science, 117312 Moscow, Russia
| | - K Piasecki
- Uniwersytet Warszawski, Wydział Fizyki, Instytut Fizyki Doświadczalnej, 02-093 Warszawa, Poland
| | - J Pietraszko
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - W Przygoda
- Smoluchowski Institute of Physics, Jagiellonian University of Cracow, 30-059 Kraków, Poland
| | - K Pysz
- Institute of Nuclear Physics, Polish Academy of Sciences, 31342 Kraków, Poland
| | - S Ramos
- LIP-Laboratório de Instrumentação e Física Experimental de Partículas, 3004-516 Coimbra, Portugal
| | - B Ramstein
- Laboratoire de Physique des 2 infinis Irène Joliot-Curie, Université Paris-Saclay, CNRS-IN2P3, F-91405 Orsay, France
| | - N Rathod
- Smoluchowski Institute of Physics, Jagiellonian University of Cracow, 30-059 Kraków, Poland
| | - A Reshetin
- Institute for Nuclear Research, Russian Academy of Science, 117312 Moscow, Russia
| | - P Rodriguez-Ramos
- Nuclear Physics Institute, The Czech Academy of Sciences, 25068 Rez, Czech Republic
| | - P Rosier
- Laboratoire de Physique des 2 infinis Irène Joliot-Curie, Université Paris-Saclay, CNRS-IN2P3, F-91405 Orsay, France
| | - A Rost
- Technische Universität Darmstadt, 64289 Darmstadt, Germany
| | - A Rustamov
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - A Sadovsky
- Institute for Nuclear Research, Russian Academy of Science, 117312 Moscow, Russia
| | - P Salabura
- Smoluchowski Institute of Physics, Jagiellonian University of Cracow, 30-059 Kraków, Poland
| | - T Scheib
- Institut für Kernphysik, Goethe-Universität, 60438 Frankfurt, Germany
| | - H Schuldes
- Institut für Kernphysik, Goethe-Universität, 60438 Frankfurt, Germany
| | - E Schwab
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - F Scozzi
- Technische Universität Darmstadt, 64289 Darmstadt, Germany
- Laboratoire de Physique des 2 infinis Irène Joliot-Curie, Université Paris-Saclay, CNRS-IN2P3, F-91405 Orsay, France
| | - F Seck
- Technische Universität Darmstadt, 64289 Darmstadt, Germany
| | - P Sellheim
- Institut für Kernphysik, Goethe-Universität, 60438 Frankfurt, Germany
| | - I Selyuzhenkov
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia
| | - J Siebenson
- Physik Department E62, Technische Universität München, 85748 Garching, Germany
| | - L Silva
- LIP-Laboratório de Instrumentação e Física Experimental de Partículas, 3004-516 Coimbra, Portugal
| | - U Singh
- Smoluchowski Institute of Physics, Jagiellonian University of Cracow, 30-059 Kraków, Poland
| | - J Smyrski
- Smoluchowski Institute of Physics, Jagiellonian University of Cracow, 30-059 Kraków, Poland
| | - Yu G Sobolev
- Nuclear Physics Institute, The Czech Academy of Sciences, 25068 Rez, Czech Republic
| | - S Spataro
- Dipartimento di Fisica and INFN, Università di Torino, 10125 Torino, Italy
| | - S Spies
- Institut für Kernphysik, Goethe-Universität, 60438 Frankfurt, Germany
| | - H Ströbele
- Institut für Kernphysik, Goethe-Universität, 60438 Frankfurt, Germany
| | - J Stroth
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
- Institut für Kernphysik, Goethe-Universität, 60438 Frankfurt, Germany
| | - C Sturm
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - O Svoboda
- Nuclear Physics Institute, The Czech Academy of Sciences, 25068 Rez, Czech Republic
| | - M Szala
- Institut für Kernphysik, Goethe-Universität, 60438 Frankfurt, Germany
| | - P Tlusty
- Nuclear Physics Institute, The Czech Academy of Sciences, 25068 Rez, Czech Republic
| | - M Traxler
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - H Tsertos
- Department of Physics, University of Cyprus, 1678 Nicosia, Cyprus
| | - E Usenko
- Institute for Nuclear Research, Russian Academy of Science, 117312 Moscow, Russia
| | - V Wagner
- Nuclear Physics Institute, The Czech Academy of Sciences, 25068 Rez, Czech Republic
| | - C Wendisch
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - M G Wiebusch
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - J Wirth
- Excellence Cluster "Origin and Structure of the Universe," 85748 Garching, Germany
- Physik Department E62, Technische Universität München, 85748 Garching, Germany
| | - D Wójcik
- Uniwersytet Warszawski, Wydział Fizyki, Instytut Fizyki Doświadczalnej, 02-093 Warszawa, Poland
| | - Y Zanevsky
- Joint Institute of Nuclear Research, 141980 Dubna, Russia
| | - P Zumbruch
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| |
Collapse
|
7
|
Pabel S, Knierim M, Alebrand F, Paulus M, Herting J, Hollemann D, Sedej S, Von Lewinski D, Fischer T, Schmid C, Hasenfuss G, Brochhausen C, Maier L, Streckfuss-Boemeke K, Sossalla S. Atrial fibrillation impairs ventricular function by altering excitation-contraction coupling in the human heart. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.3711] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Atrial fibrillation (AF) often co-exists in patients with heart failure (HF). Recent clinical evidence suggests that the arrhythmic component of AF alone may contribute to ventricular dysfunction. However, the pathophysiological effects of a non-tachycardic AF on the human ventricle are unknown. To investigate the effects of normofrequent AF on the human ventricle we investigated ventricular myocardium from patients with preserved ejection fraction with sinus rhythm (SR) or AF in the absence of HF (compensated hypertrophy, EF>50%, matched clinical characteristics). In histological analysis we detected no difference between SR (n=9) vs. AF (n=6) regarding the amount and distribution of fibrosis. For functional investigation, Ca-handling was studied (Fura-2 AM). While systolic Ca-transient amplitude was in trend reduced in isolated human ventricular AF cardiomyocytes, we found a significantly prolonged Ca-elimination time (n=17–22 cells/4 pat.). Using caffeine application, a decreased SR Ca-load in AF was detected, which may be explained by a significant decrease in SERCA2a activity (ksys-kCaff, n=10–12/4 pat.). Patch-clamp experiments revealed a prolonged action potential duration in AF cardiomyocytes (n=5/15 cells).
For the standardized evaluation of the mechanisms of persistent normofrequent arrhythmia, we simulated AF in vitro by using arrhythmic (1 Hz, 40% R-R-variability) or rhythmic (1 Hz) field stimulation. We performed contractility experiments using in-toto isolated human ventricular trabeculae from explanted human hearts. After 8h of pacing, arrhythmically stimulated human trabeculae showed a significantly reduced systolic force, an increase in diastolic tension and a prolonged relaxation (n=11–12 trabeculae/11 pat.). For studying the cellular effects of persistent normofrequent arrhythmia in a model suitable for chronic pacing (up to 7 days), we utilized human iPSC cardiomyocytes (iPSC-CM) from healthy donors (n=6). After 7 days, arrhythmic paced iPSC-CM showed a significantly reduced systolic Ca-transient amplitude, a prolonged Ca-elimination time (n=35/45 cells) as well as a reduced SR Ca-load and a trend towards a lower SERCA2a activity compared to control (n=11 cells). Confocal line-scans (Fluo-4 AM) showed an increased diastolic SR Ca-release, which might also explain the reduced SR Ca-content (n=45/35 cells). Moreover, in irregularly paced iPSC-CM we found significant increased levels of cytosolic Na (n=69 cells each) and in patch-clamp experiments a significantly prolonged action potential duration (n=14/11 cells/3 diff.).
This study demonstrates that a normofrequent arrhythmic ventricular excitation as it occurs in AF impairs human ventricular myocardial function by altering cardiomyocyte excitation-contraction coupling. Thus, this study provides the first translational mechanistic characterization and the potential negative impact of isolated AF in the absence of tachycardia on the human ventricle.
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- S Pabel
- University hospital Regensburg, Regensburg, Germany
| | - M Knierim
- University Medical Center Gottingen (UMG), Dept. of Cardiology and Pneumology, Heart Center, Gottingen, Germany
| | - F Alebrand
- University Medical Center Gottingen (UMG), Dept. of Cardiology and Pneumology, Heart Center, Gottingen, Germany
| | - M Paulus
- University hospital Regensburg, Regensburg, Germany
| | - J Herting
- University Medical Center Gottingen (UMG), Dept. of Cardiology and Pneumology, Heart Center, Gottingen, Germany
| | - D Hollemann
- University of Regensburg, Institute of Pathology, Regensburg, Germany
| | - S Sedej
- Medical University of Graz, Department of Cardiology, Graz, Austria
| | - D Von Lewinski
- Medical University of Graz, Department of Cardiology, Graz, Austria
| | - T Fischer
- University Hospital Wuerzburg, Wuerzburg, Germany
| | - C Schmid
- University hospital Regensburg, Regensburg, Germany
| | - G Hasenfuss
- University Medical Center Gottingen (UMG), Dept. of Cardiology and Pneumology, Heart Center, Gottingen, Germany
| | - C Brochhausen
- University of Regensburg, Institute of Pathology, Regensburg, Germany
| | - L Maier
- University hospital Regensburg, Regensburg, Germany
| | - K Streckfuss-Boemeke
- University Medical Center Gottingen (UMG), Dept. of Cardiology and Pneumology, Heart Center, Gottingen, Germany
| | - S Sossalla
- University hospital Regensburg, Regensburg, Germany
| |
Collapse
|
8
|
Knierim M, Pabel S, Paulus M, Rainer P, Scherr D, Hasenfuss G, Maier L, Streckfuss-Boemeke K, Sossalla S. Cellular mechanisms of early tachycardia-induced ventricular dysfunction in the human heart. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.3680] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Tachycardia-induced cardiomyopathy (TCM) is a reversible form of ventricular dysfunction caused by persistent tachycardia. Characterization of TCM is mainly based on artificially RV paced animal models. Moreover, the underlying mechanisms and time course from compensation to failure remain unclear. This study aimed to investigate early cellular remodeling of tachycardia-induced myocardial dysfunction in human myocardium.
Methods and results
To elucidate early cellular electrophysiological targets mediating the transition to TCM, we chronically paced (120bpm vs 60bpm control) human induced pluripotent stem cell cardiomyocytes (hiPS-CM) for up to 7d. As a major substrate of cellular myocardial dysfunction, we investigated the influence of chronic tachycardia on cellular Ca cycling. After 24h of persistent tachycardia we detected a significant decrease in Ca transient (CaT) amplitude and reduced diastolic Ca levels (Fura-2). Meanwhile, Ca elimination time (RT80) was unchanged compared to control (n=44/42 cells / 8 diff.). Caffeine application was performed to evaluate sarcoplasmic reticulum (SR) Ca load. We found a shortening of caffeine-induced CaT relaxation time, whereas SR Ca load was unchanged (n=12/13 /8). Further illustrating the transition to TCM, CaT amplitude was progressively decreased after 7d of chronic tachycardia. In contrast to 24h of tachycardia, 7d persistent stimulation resulted in slowed relaxation (RT80, n=75/65 /7). These findings could be explained by a significant reduction of SERCA activity (Ksys-Kcaff) and SR Ca load (n=14/12 / 7). Diastolic Ca concentration remained reduced (n=75/65 /7), in total suggesting a shift to transsarcolemmal Ca elimination.
Sodium measurements (SBFI) revealed a significant increase of intracellular sodium concentration (n=69/69 /5) after 7d of tachycardia.
In patch clamp experiments we detected a prolongation of action potential duration as early as 24h after onset of tachycardia (n=26/21 /4), which persisted throughout 7d of pacing (n=8/12 /3). Resting membrane potential and action potential amplitude were not changed.
Finally, we investigated tachycardia-mediated effects on pre-existing human heart failure (HF). 8h tachycardic stimulation (120bpm) of human HF ventricular trabeculae compromised systolic force, while diastolic tension and relaxation time were markedly increased compared to control (60bpm) (n=7/6 trabeculae /6 human hearts).
The extensive molecular characterization of involved ion channels and pathways mediating transition to TCM is currently under investigation.
Conclusion
This study demonstrates that a persistent tachycardia adversely alters cardiomyocyte excitation-contraction coupling via early electrophysiological cellular remodeling. In pre-existing HF persistent tachycardia strongly aggravates ventricular dysfunction. Our first translational investigation in human myocardium may help to understand the pathophysiology of an underrated and very prevalent disease.
Funding Acknowledgement
Type of funding source: Foundation. Main funding source(s): Else-Kröner-Fresenius-Stiftung
Collapse
Affiliation(s)
- M Knierim
- University Medical Center of Gottingen (UMG), Goettingen, Germany
| | - S Pabel
- University hospital Regensburg, Regensburg, Germany
| | - M Paulus
- University hospital Regensburg, Regensburg, Germany
| | - P Rainer
- Medical University of Graz, Graz, Austria
| | - D Scherr
- Medical University of Graz, Graz, Austria
| | - G Hasenfuss
- University Medical Center of Gottingen (UMG), Goettingen, Germany
| | - L Maier
- University hospital Regensburg, Regensburg, Germany
| | | | - S Sossalla
- University hospital Regensburg, Regensburg, Germany
| |
Collapse
|
9
|
Langer T, Clemens E, Broer L, Maier L, Uitterlinden AG, de Vries AC, van Grotel M, Pluijm SF, Binder H, Mayer B, von dem Knesebeck A, Byrne J, van Dulmen-den Broeder E, Crocco M, Grabow D, Kaatsch P, Kaiser M, Spix C, Kenborg L, Winther JF, Rechnitzer C, Hasle H, Kepak T, van der Kooi ALF, Kremer LC, Kruseova J, Bielack S, Sorg B, Hecker-Nolting S, Kuehni CE, Ansari M, Kompis M, van der Pal HJ, Parfitt R, Deuster D, Matulat P, Tillmanns A, Tissing WJ, Beck JD, Elsner S, am Zehnhoff-Dinnesen A, van den Heuvel-Eibrink MM, Zolk O. Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset. Data Brief 2020; 32:106227. [PMID: 32939381 PMCID: PMC7477761 DOI: 10.1016/j.dib.2020.106227] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2020] [Accepted: 08/21/2020] [Indexed: 11/17/2022] Open
Abstract
Genetic association studies suggest a genetic predisposition for cisplatin-induced ototoxicity. Among other candidate genes, thiopurine methyltransferase (TPMT) is considered a critical gene for susceptibility to cisplatin-induced hearing loss in a pharmacogenetic guideline. The PanCareLIFE cross-sectional cohort study evaluated the genetic associations in a large pan-European population and assessed the diagnostic accuracy of the genetic markers. 1,112 pediatric cancer survivors who had provided biomaterial for genotyping were screened for participation in the pharmacogenetic association study. 900 participants qualified for inclusion. Based on the assessment of original audiograms, patients were assigned to three phenotype categories: no, minor, and clinically relevant hearing loss. Fourteen variants in eleven candidate genes (ABCC3, OTOS, TPMT, SLC22A2, NFE2L2, SLC16A5, LRP2, GSTP1, SOD2, WFS1, and ACYP2) were genotyped. The genotype and phenotype data represent a resource for conducting meta-analyses to derive a more precise pooled estimate of the effects of genes on the risk of hearing loss due to platinum treatment.
Collapse
Affiliation(s)
- Thorsten Langer
- Department of Pediatric Oncology and Hematology, University Hospital for Children and Adolescents, Lübeck, Germany
| | - Eva Clemens
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
- Department of Pediatric Oncology, Erasmus MC – Sophia Children's Hospital, Rotterdam, The Netherlands
| | - Linda Broer
- Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
| | - Lara Maier
- Institute of Pharmacology of Natural Products and Clinical Pharmacology, Ulm University Medical Center, Ulm, Germany
| | | | - Andrica C.H. de Vries
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
- Department of Pediatric Oncology, Erasmus MC – Sophia Children's Hospital, Rotterdam, The Netherlands
| | | | | | - Harald Binder
- German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
- Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany
| | - Benjamin Mayer
- Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany
| | - Annika von dem Knesebeck
- Department of Pediatric Oncology and Hematology, University Hospital for Children and Adolescents, Lübeck, Germany
| | | | - Eline van Dulmen-den Broeder
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
- Department of Pediatric Hematology and Oncology, VU Medical Center, Amsterdam, The Netherlands
| | - Marco Crocco
- Department of Neurooncology, Istituto Giannina Gaslini, Genova, Italy
| | - Desiree Grabow
- German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
| | - Peter Kaatsch
- German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
| | - Melanie Kaiser
- German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
| | - Claudia Spix
- German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
| | - Line Kenborg
- Danish Cancer Society Research Center, Childhood Cancer Research Group, Copenhagen, Denmark
| | - Jeanette F. Winther
- Danish Cancer Society Research Center, Childhood Cancer Research Group, Copenhagen, Denmark
- Department of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark
| | - Catherine Rechnitzer
- Copenhagen University Hospital Rigshospitalet, Department of Pediatrics and Adolescent Medicine, Copenhagen, Denmark
| | - Henrik Hasle
- Aarhus University Hospital, Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark
| | - Tomas Kepak
- University Hospital Brno, Brno, Czech Republic, & International Clinical Research Center (FNUSA-ICRC), Brno, Czech Republic
| | - Anne-Lotte F. van der Kooi
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
- Department of Obstetrics and Gynecology, Erasmus MC – Sophia Children's Hospital, The Netherlands
| | - Leontien C. Kremer
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
- Department of Pediatric Oncology, Academic Medical Center Amsterdam, Amsterdam, The Netherlands
| | - Jarmila Kruseova
- Department of Children Hemato-Oncology, Motol University Hospital Prague, Prague, Czech Republic
| | - Stefan Bielack
- Department of Pediatric Oncology, Hematology, Immunology, Stuttgart Cancer Center, Olgahospital, Stuttgart, Germany
| | - Benjamin Sorg
- Department of Pediatric Oncology, Hematology, Immunology, Stuttgart Cancer Center, Olgahospital, Stuttgart, Germany
| | - Stefanie Hecker-Nolting
- Department of Pediatric Oncology, Hematology, Immunology, Stuttgart Cancer Center, Olgahospital, Stuttgart, Germany
| | - Claudia E. Kuehni
- Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
- Paediatric Oncology, Dept. of Paediatrics, Inselspital, University of Bern, Switzerland
| | - Marc Ansari
- Department of Pediatrics, Oncology and Hematology Unit, University Hospital of Geneva, Cansearch Research Laboratory, Geneva University, Switzerland
| | - Martin Kompis
- Department of Otolaryngology, Head and Neck Surgery, Inselspital, University of Berne
| | - Heleen J. van der Pal
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
- Department of Pediatric Oncology, Academic Medical Center Amsterdam, Amsterdam, The Netherlands
| | - Ross Parfitt
- Department of Phoniatrics and Pedaudiology, University Hospital Münster, Westphalian Wilhelm University, Münster, Germany
| | - Dirk Deuster
- Department of Phoniatrics and Pedaudiology, University Hospital Münster, Westphalian Wilhelm University, Münster, Germany
| | - Peter Matulat
- Department of Phoniatrics and Pedaudiology, University Hospital Münster, Westphalian Wilhelm University, Münster, Germany
| | - Amelie Tillmanns
- Department of Phoniatrics and Pedaudiology, University Hospital Münster, Westphalian Wilhelm University, Münster, Germany
| | - Wim J.E. Tissing
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
- Department of Pediatric Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
| | - Jörn D. Beck
- Hospital for Children and Adolescents, University of Erlangen-Nuremberg, Erlangen, Germany
| | - Susanne Elsner
- Institute for Social Medicine and Epidemiology, University of Lübeck, Lübeck, Germany
| | | | - Marry M. van den Heuvel-Eibrink
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
- Department of Pediatric Oncology, Erasmus MC – Sophia Children's Hospital, Rotterdam, The Netherlands
| | - Oliver Zolk
- Institute of Pharmacology of Natural Products and Clinical Pharmacology, Ulm University Medical Center, Ulm, Germany
- Institute of Clinical Pharmacology, Immanuel Klinik Rüdersdorf, Brandenburg Medical School Theodor Fontane, Germany
| | - PanCareLIFE consortium
- Department of Pediatric Oncology and Hematology, University Hospital for Children and Adolescents, Lübeck, Germany
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
- Department of Pediatric Oncology, Erasmus MC – Sophia Children's Hospital, Rotterdam, The Netherlands
- Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
- Institute of Pharmacology of Natural Products and Clinical Pharmacology, Ulm University Medical Center, Ulm, Germany
- German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
- Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany
- Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany
- Boyne Research Institute, Drogheda, Ireland
- Department of Pediatric Hematology and Oncology, VU Medical Center, Amsterdam, The Netherlands
- Department of Neurooncology, Istituto Giannina Gaslini, Genova, Italy
- Danish Cancer Society Research Center, Childhood Cancer Research Group, Copenhagen, Denmark
- Department of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark
- Copenhagen University Hospital Rigshospitalet, Department of Pediatrics and Adolescent Medicine, Copenhagen, Denmark
- Aarhus University Hospital, Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark
- University Hospital Brno, Brno, Czech Republic, & International Clinical Research Center (FNUSA-ICRC), Brno, Czech Republic
- Department of Obstetrics and Gynecology, Erasmus MC – Sophia Children's Hospital, The Netherlands
- Department of Pediatric Oncology, Academic Medical Center Amsterdam, Amsterdam, The Netherlands
- Department of Children Hemato-Oncology, Motol University Hospital Prague, Prague, Czech Republic
- Department of Pediatric Oncology, Hematology, Immunology, Stuttgart Cancer Center, Olgahospital, Stuttgart, Germany
- Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
- Paediatric Oncology, Dept. of Paediatrics, Inselspital, University of Bern, Switzerland
- Department of Pediatrics, Oncology and Hematology Unit, University Hospital of Geneva, Cansearch Research Laboratory, Geneva University, Switzerland
- Department of Otolaryngology, Head and Neck Surgery, Inselspital, University of Berne
- Department of Phoniatrics and Pedaudiology, University Hospital Münster, Westphalian Wilhelm University, Münster, Germany
- Department of Pediatric Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
- Hospital for Children and Adolescents, University of Erlangen-Nuremberg, Erlangen, Germany
- Institute for Social Medicine and Epidemiology, University of Lübeck, Lübeck, Germany
- Institute of Clinical Pharmacology, Immanuel Klinik Rüdersdorf, Brandenburg Medical School Theodor Fontane, Germany
| |
Collapse
|
10
|
Langer T, Clemens E, Broer L, Maier L, Uitterlinden AG, de Vries ACH, van Grotel M, Pluijm SFM, Binder H, Mayer B, von dem Knesebeck A, Byrne J, van Dulmen-den Broeder E, Crocco M, Grabow D, Kaatsch P, Kaiser M, Spix C, Kenborg L, Winther JF, Rechnitzer C, Hasle H, Kepak T, van der Kooi ALF, Kremer LC, Kruseova J, Bielack S, Sorg B, Hecker-Nolting S, Kuehni CE, Ansari M, Kompis M, van der Pal H, Parfitt R, Deuster D, Matulat P, Tillmanns A, Tissing WJE, Beck JD, Elsner S, Am Zehnhoff-Dinnesen A, van den Heuvel-Eibrink MM, Zolk O. Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study. Eur J Cancer 2020; 138:212-224. [PMID: 32905960 DOI: 10.1016/j.ejca.2020.07.019] [Citation(s) in RCA: 25] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2020] [Revised: 07/22/2020] [Accepted: 07/29/2020] [Indexed: 01/12/2023]
Abstract
BACKGROUND Irreversible sensorineural hearing loss is a common side effect of platinum treatment with the potential to significantly impair the neurocognitive, social and educational development of childhood cancer survivors. Genetic association studies suggest a genetic predisposition for cisplatin-induced ototoxicity. Among other candidate genes, thiopurine methyltransferase (TPMT) is considered a critical gene for susceptibility to cisplatin-induced hearing loss in a pharmacogenetic guideline. The aim of this cross-sectional cohort study was to confirm the genetic associations in a large pan-European population and to evaluate the diagnostic accuracy of the genetic markers. METHODS Eligibility criteria required patients to be aged less than 19 years at the start of chemotherapy, which had to include cisplatin and/or carboplatin. Patients were assigned to three phenotype categories: no, minor and clinically relevant hearing loss. Fourteen variants in eleven candidate genes (ABCC3, OTOS, TPMT, SLC22A2, NFE2L2, SLC16A5, LRP2, GSTP1, SOD2, WFS1 and ACYP2) were investigated. Multinomial logistic regression was performed to model the relationship between genetic predictors and platinum ototoxicity, adjusting for clinical risk factors. Additionally, measures of the diagnostic accuracy of the genetic markers were determined. RESULTS 900 patients were included in this study. In the multinomial logistic regression, significant unique contributions were found from SLC22A2 rs316019, the age at the start of platinum treatment, cranial radiation and the interaction term [platinum compound]∗[cumulative dose of cisplatin]. The predictive performance of the genetic markers was poor compared with the clinical risk factors. CONCLUSIONS PanCareLIFE is the largest study of cisplatin-induced ototoxicity to date and confirmed a role for the polyspecific organic cation transporter SLC22A2. However, the predictive value of the current genetic candidate markers for clinical use is negligible, which puts the value of clinical factors for risk assessment of cisplatin-induced ototoxicity back into the foreground.
Collapse
Affiliation(s)
- Thorsten Langer
- Department of Pediatric Oncology and Hematology, University Hospital for Children and Adolescents, Lübeck, Germany
| | - Eva Clemens
- Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pediatric Oncology, Erasmus MC - Sophia Children's Hospital, Rotterdam, the Netherlands
| | - Linda Broer
- Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Lara Maier
- Institute of Pharmacology of Natural Products and Clinical Pharmacology, Ulm University Medical Center, Ulm, Germany
| | - André G Uitterlinden
- Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands
| | - Andrica C H de Vries
- Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pediatric Oncology, Erasmus MC - Sophia Children's Hospital, Rotterdam, the Netherlands
| | | | - Saskia F M Pluijm
- Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
| | - Harald Binder
- German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany; Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany
| | - Benjamin Mayer
- Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany
| | - Annika von dem Knesebeck
- Department of Pediatric Oncology and Hematology, University Hospital for Children and Adolescents, Lübeck, Germany
| | | | - Eline van Dulmen-den Broeder
- Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pediatric Hematology and Oncology, VU Medical Center, Amsterdam, the Netherlands
| | - Marco Crocco
- Department of Neurooncology, Istituto Giannina Gaslini, Genova, Italy
| | - Desiree Grabow
- German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
| | - Peter Kaatsch
- German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
| | - Melanie Kaiser
- German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
| | - Claudia Spix
- German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
| | - Line Kenborg
- Danish Cancer Society Research Center, Childhood Cancer Research Group, Copenhagen, Denmark
| | - Jeanette F Winther
- Danish Cancer Society Research Center, Childhood Cancer Research Group, Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark
| | - Catherine Rechnitzer
- Copenhagen University Hospital Rigshospitalet, Department of Pediatrics and Adolescent Medicine, Copenhagen, Denmark
| | - Henrik Hasle
- Aarhus University Hospital, Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark
| | - Tomas Kepak
- University Hospital Brno, Brno, Czech Republic; International Clinical Research Center (FNUSA-ICRC), Brno, Czech Republic
| | - Anne-Lotte F van der Kooi
- Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Obstetrics and Gynecology, Erasmus MC - Sophia Children's Hospital, the Netherlands
| | - Leontien C Kremer
- Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pediatric Oncology, Academic Medical Center Amsterdam, Amsterdam, the Netherlands
| | - Jarmila Kruseova
- Department of Children Hemato-Oncology, Motol University Hospital Prague, Prague, Czech Republic
| | - Stefan Bielack
- Department of Pediatric Oncology, Hematology, Immunology, Stuttgart Cancer Center, Olgahospital, Stuttgart, Germany
| | - Benjamin Sorg
- Department of Pediatric Oncology, Hematology, Immunology, Stuttgart Cancer Center, Olgahospital, Stuttgart, Germany
| | - Stefanie Hecker-Nolting
- Department of Pediatric Oncology, Hematology, Immunology, Stuttgart Cancer Center, Olgahospital, Stuttgart, Germany
| | - Claudia E Kuehni
- Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Paediatric Oncology, Dept. of Paediatrics, Inselspital, University of Bern, Switzerland
| | - Marc Ansari
- Department of Pediatrics, Oncology and Hematology Unit, University Hospital of Geneva, Cansearch Research Laboratory, Geneva University, Switzerland
| | - Martin Kompis
- Department of Otolaryngology, Head and Neck Surgery, Inselspital, University of Berne, Switzerland
| | - Heleen van der Pal
- Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pediatric Oncology, Academic Medical Center Amsterdam, Amsterdam, the Netherlands
| | - Ross Parfitt
- Department of Phoniatrics and Pedaudiology, University Hospital Münster, Westphalian Wilhelm University, Münster, Germany
| | - Dirk Deuster
- Department of Phoniatrics and Pedaudiology, University Hospital Münster, Westphalian Wilhelm University, Münster, Germany
| | - Peter Matulat
- Department of Phoniatrics and Pedaudiology, University Hospital Münster, Westphalian Wilhelm University, Münster, Germany
| | - Amelie Tillmanns
- Department of Phoniatrics and Pedaudiology, University Hospital Münster, Westphalian Wilhelm University, Münster, Germany
| | - Wim J E Tissing
- Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pediatric Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | - Jörn D Beck
- Hospital for Children and Adolescents, University of Erlangen-Nuremberg, Erlangen, Germany
| | - Susanne Elsner
- Institute for Social Medicine and Epidemiology, University of Lübeck, Lübeck, Germany
| | | | - Marry M van den Heuvel-Eibrink
- Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pediatric Oncology, Erasmus MC - Sophia Children's Hospital, Rotterdam, the Netherlands
| | - Oliver Zolk
- Institute of Clinical Pharmacology, Immanuel Klinik Rüdersdorf, Brandenburg Medical School Theodor Fontane, Germany; Institute of Pharmacology of Natural Products and Clinical Pharmacology, Ulm University Medical Center, Ulm, Germany.
| | | |
Collapse
|
11
|
Heys C, Cheaib B, Busetti A, Kazlauskaite R, Maier L, Sloan WT, Ijaz UZ, Kaufmann J, McGinnity P, Llewellyn MS. Neutral Processes Dominate Microbial Community Assembly in Atlantic Salmon, Salmo salar. Appl Environ Microbiol 2020; 86:e02283-19. [PMID: 32033945 PMCID: PMC7117918 DOI: 10.1128/aem.02283-19] [Citation(s) in RCA: 40] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2019] [Accepted: 01/18/2020] [Indexed: 01/31/2023] Open
Abstract
In recent years, a wealth of studies has examined the relationships between a host and its microbiome across diverse taxa. Many studies characterize the host microbiome without considering the ecological processes that underpin microbiome assembly. In this study, the intestinal microbiota of Atlantic salmon, Salmo salar, sampled from farmed and wild environments was first characterized using 16S rRNA gene MiSeq sequencing analysis. We used neutral community models to determine the balance of stochastic and deterministic processes that underpin microbial community assembly and transfer across life cycle stage and between gut compartments. Across gut compartments in farmed fish, neutral models suggest that most microbes are transient with no evidence of adaptation to their environment. In wild fish, we found declining taxonomic and functional microbial community richness as fish mature through different life cycle stages. Alongside neutral community models applied to wild fish, we suggest that declining richness demonstrates an increasing role for the host in filtering microbial communities that is correlated with age. We found a limited subset of gut microflora adapted to the farmed and wild host environment among which Mycoplasma spp. are prominent. Our study reveals the ecological drivers underpinning community assembly in both farmed and wild Atlantic salmon and underlines the importance of understanding the role of stochastic processes, such as random drift and small migration rates in microbial community assembly, before considering any functional role of the gut microbes encountered.IMPORTANCE A growing number of studies have examined variation in the microbiome to determine the role in modulating host health, physiology, and ecology. However, the ecology of host microbial colonization is not fully understood and rarely tested. The continued increase in production of farmed Atlantic salmon, coupled with increased farmed-wild salmon interactions, has accentuated the need to unravel the potential adaptive function of the microbiome and to distinguish resident from transient gut microbes. Between gut compartments in a farmed system, we found a majority of operational taxonomic units (OTUs) that fit the neutral model, with Mycoplasma species among the key exceptions. In wild fish, deterministic processes account for more OTU differences across life stages than those observed across gut compartments. Unlike previous studies, our results make detailed comparisons between fish from wild and farmed environments, while also providing insight into the ecological processes underpinning microbial community assembly in this ecologically and economically important species.
Collapse
Affiliation(s)
- C Heys
- Institute of Behaviour, Animal Health and Comparative Medicine, University of Glasgow, Glasgow, United Kingdom
| | - B Cheaib
- School of Engineering, University of Glasgow, Glasgow, United Kingdom
| | - A Busetti
- Institute of Behaviour, Animal Health and Comparative Medicine, University of Glasgow, Glasgow, United Kingdom
| | - R Kazlauskaite
- Institute of Behaviour, Animal Health and Comparative Medicine, University of Glasgow, Glasgow, United Kingdom
| | - L Maier
- Institute of Behaviour, Animal Health and Comparative Medicine, University of Glasgow, Glasgow, United Kingdom
| | - W T Sloan
- School of Engineering, University of Glasgow, Glasgow, United Kingdom
| | - U Z Ijaz
- School of Engineering, University of Glasgow, Glasgow, United Kingdom
| | - J Kaufmann
- School of Biological, Earth & Environmental Sciences, University College Cork, Cork, Ireland
| | - P McGinnity
- School of Biological, Earth & Environmental Sciences, University College Cork, Cork, Ireland
- Marine Institute, Newport, Ireland
| | - M S Llewellyn
- Institute of Behaviour, Animal Health and Comparative Medicine, University of Glasgow, Glasgow, United Kingdom
| |
Collapse
|
12
|
Volc S, Maier L, Gritsch A, Aichelburg MC, Volc-Platzer B. Successful treatment of Netherton syndrome with ustekinumab in a 15-year-old girl. Br J Dermatol 2020; 183:165-167. [PMID: 31977080 DOI: 10.1111/bjd.18892] [Citation(s) in RCA: 31] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Affiliation(s)
- S Volc
- Department of Dermatology, Eberhard-Karls-University Tübingen, Tübingen, Germany
| | - L Maier
- Department of Dermatology, Donauspital Vienna, Vienna, Austria.,Karl Landsteiner Institute for Paediatric Dermatology, Vienna, Austria
| | - A Gritsch
- Department of Dermatology, Donauspital Vienna, Vienna, Austria
| | - M C Aichelburg
- Department of Dermatology, Donauspital Vienna, Vienna, Austria
| | - B Volc-Platzer
- Department of Dermatology, Donauspital Vienna, Vienna, Austria.,Karl Landsteiner Institute for Paediatric Dermatology, Vienna, Austria
| |
Collapse
|
13
|
|
14
|
Meindl C, Hamerle M, Rogalski D, Paulus M, Schach C, Maier L, Debl K, Birner C, Unsoeld B. P5571MitraClip implantation impairs functional echocardiographic parameters of the left atrium in patients with moderate to severe mitral regurgitation. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.0515] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
MitraClip implantation induces hemodynamic unloading and reverse remodeling of the left atrium (LA) and the left ventricle (LV). However little data exist concerning the effects of MitraClip implantation on LA and LV strain reflecting LA and LV function.
Methods and results
From August 2017 to September 2018 62 patients with moderate to severe mitral regurgitation were prospectively enrolled in our single-center RETORT-MR trial (Regensburg Trial on TMVR Techniques in Mitral Regurgitation). All included patients were treated using the MitraClip procedure. Two dimensional speckle tracking echocardiography (2DSTE) of the LA as well as of the LV could be performed in 35 patients with follow-up 2DSTE at four weeks and/or three months after MitraClip implantation. In 25.7% of patients primary mitral regurgitation was present (n=9) and in 74.3% of subjects a secondary entity of mitral regurgitation had been diagnosed (n=26). 57.1% of patients (n=20) suffered from heart failure with preserved ejection fraction (HFpEF) and 42.9% of patients (n=15) had heart failure with reduced ejection fraction (HFrEF). Global longitudinal strain (GLS) was reduced at baseline (−15.3%), at four-week (−14.5%, n=27) and at three-month follow-up (−13.9%, n=28) with no statistically significant differences indicating a sustained mechanical impairment of LV. In contrast significant deterioration was observed in the peak atrial longitudinal strain (PALS) representing LA reservoir function (15.3% at baseline vs. 11.8% at four-week follow-up, n=25, p=0.015 and 16.0% at baseline vs. 13.2% at three-month follow-up, n=25, p=0.03). Similarly to LA reservoir function LA booster function indicating left atrial active contraction was significantly reduced after MitraClip implantation (12.5% at baseline vs. 8.0% at four-week follow-up, n=10, p=0.028). Contrary to LA functional parameters LA size did not change significantly after MitraClip implantation (LA volume index at baseline 74.5 ml/m2 vs. 70.1 ml/m2 at four-week follow-up, n=27, p=0.489).
Conclusion
The present study revealed a deterioration of LA functional parameters (LA reservoir and LA booster function) after MitraClip insertion. It is known that severe mitral regurgitation can cause structural changes of the LA such as fibrosis. MitraClip insertion leads to a significant reduction of regurgitant volumes but structural changes of the LA may not be reversible. In addition MitraClip implantation increases afterload in the LA potentially explaining the observed deterioration of LA functional parameters.
Acknowledgement/Funding
None
Collapse
Affiliation(s)
- C Meindl
- University Hospital Regensburg, Regensburg, Germany
| | - M Hamerle
- University Hospital Regensburg, Regensburg, Germany
| | - D Rogalski
- University Hospital Regensburg, Regensburg, Germany
| | - M Paulus
- University Hospital Regensburg, Regensburg, Germany
| | - C Schach
- University Hospital Regensburg, Regensburg, Germany
| | - L Maier
- University Hospital Regensburg, Regensburg, Germany
| | - K Debl
- University Hospital Regensburg, Regensburg, Germany
| | - C Birner
- St. Marien Hospital, Amberg, Germany
| | - B Unsoeld
- University Hospital Regensburg, Regensburg, Germany
| |
Collapse
|
15
|
Caforio A, Gianstefani S, Baritussio A, Marcolongo R, Seguso M, Gallo N, Plebani M, Izquierdo-Bajo A, Cheng CY, Iliceto S, Semenzato GP, Maier L, Hamzeh N. 1173Anti-heart and anti-intercalated disk autoantibodies: possible novel biomarkers of cardiac sarcoidosis. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz748.0015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Sarcoidosis is an immune-mediated disease; cardiac involvement, a granulomatous form of myocarditis, is under-recognised and prognostically relevant, as it can present with significant morbidity and mortality. Anti-heart autoantibodies (AHA) and anti-intercalated disk autoantibodies (AIDA) are reliable autoimmune markers in non-sarcoidosis myocarditis forms.
Purpose
The aim of this study was to assess the potential role of serum AHA and AIDA in cardiac sarcoidosis.
Methods
This is a cross-sectional study on a series of 29 patients with biopsy proven extra-cardiac sarcoidosis and with biopsy-proven or clinically suspected cardiac involvement, who were tested for AHA and AIDA. Patients were recruited in two recruiting tertiary centres, in USA and Italy. AHA and AIDA were detected by indirect immunofluorescence on human myocardium and skeletal muscle. Controls included sera from patients with non-inflammatory cardiac disease (NICD) (n=160), with ischemic heart failure (IHF) (n=141) and normal blood donors (NBD) (n=270).
Results
The frequencies of AHA and of AIDA were higher in sarcoidosis (86%; 62%) than in NICD (8%; 4%), IHF (7%; 2%), NBD (9%; 0%) (p=0.0001; p=0.0001 respectively). Sensitivity and specificity were: 86% and 92% for positive AHA and 62% and 98% for positive AIDA, respectively (see figure).
Figure 1
Conclusions
The detection of serum AHA and AIDA in biopsy-proven or clinically suspected cardiac sarcoidosis supports the involvement of heart-specific autoimmunity in the majority of our cases and may provide a novel non invasive diagnostic marker.
Collapse
Affiliation(s)
- A Caforio
- Cardiology, Dept Cardiological Thoracic and Vascular Sciences, Padua University, Padova, Italy
| | - S Gianstefani
- Cardiology, Dept Cardiological Thoracic and Vascular Sciences, Padua University, Padova, Italy
| | - A Baritussio
- Cardiology, Dept Cardiological Thoracic and Vascular Sciences, Padua University, Padova, Italy
| | - R Marcolongo
- University of Padova, Hematology and Clinical Immunology, Department of Medicine, Padua, Italy
| | - M Seguso
- University of Padova, Department of Laboratory Medicine, Padua, Italy
| | - N Gallo
- University of Padova, Department of Laboratory Medicine, Padua, Italy
| | - M Plebani
- University of Padova, Department of Laboratory Medicine, Padua, Italy
| | - A Izquierdo-Bajo
- Cardiology, Dept Cardiological Thoracic and Vascular Sciences, Padua University, Padova, Italy
| | - C Y Cheng
- Cardiology, Dept Cardiological Thoracic and Vascular Sciences, Padua University, Padova, Italy
| | - S Iliceto
- Cardiology, Dept Cardiological Thoracic and Vascular Sciences, Padua University, Padova, Italy
| | - G P Semenzato
- University of Padova, Hematology and Clinical Immunology, Department of Medicine, Padua, Italy
| | - L Maier
- University of Denver, Department of Medicine, National Jewish Health, Denver, United States of America
| | - N Hamzeh
- University of Iowa, Division of Pulmonary, Critical Care and Occupational Medicine, Iowa City, United States of America
| |
Collapse
|
16
|
Tirilomis P, Ahmad S, Bengel P, Pabel S, Maier L, Hasenfuss G, Dybkova N, Sossalla ST. P1596Interaction of CaMKII and NaV1.8 modulates cardiac electrophysiology in human heart failure. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz748.0355] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Introduction
In human heart failure, electrical remodeling contributes to the risk of arrhythmia generation. Increased expression of Ca/Calmodulin-dependent protein kinase IIδ (CaMKIIδ) and an enhanced persistent Na current (INaL) have been linked to arrhythmogenesis. CaMKIIδ increases INaL via regulation of sodium channels thereby contributing to arrhythmias through early- and delayed-afterdepolarizations (EADs and DADs). Genome-wide association studies (GWAS) have described the implication of the neuronal sodium channel isoform NaV1.8 (SCN10A) in cardiac electrophysiology showing modulation in cardiac conduction. We showed that the expression of the isoform Nav1.8 is significantly increased in human failing cardiomyocytes and contributes substantially to the enhanced INaL.
Purpose
We investigated a potential interaction of CaMKIIδ and NaV1.8 and thereby its role in arrhythmia generation and electrophysiology in human and murine failing hearts.
Methods
Cardiomyocytes were isolated from explanted failing hearts and CaMKIIδ transgenic (TG) mice. We performed immunostainings and co-immunoprecipitation (Co-IP) to show interactions of CaMKIIδ and Nav1.8 in isolated cardiomyocytes and homogenates. Whole-cell patch clamp experiments were conducted in isolated human and murine ventricular cardiomyocytes. Additionally, Ca2+ transients were measured using epifluorescence microscopy with the Ca2+ dye fura-2 (10μmol/L) whereas Ca2+ sparks measurements were performed by using confocal microscopy with the Ca2+ dye fluo-4 (10μmol/L). PF-01247324 is a novel specific NaV1.8 inhibitor (orally bioavailable; 1 μmol/L) and autocamtide inhibitory peptide (AIP, 1 μmol/L) was used to inhibit CaMKIIδ.
Results
Co-immunoprecipitation experiments revealed an association of CaMKIIδ and Nav1.8 in human homogenates compared to healthy controls. Furthermore, immunohistochemistry stainings in isolated human cardiomyocytes showed a co-localization of CaMKIIδ and NaV1.8 at the intercalated disc and t-tubules. We observed a significant reduction of INaL integral and proarrhythmic SR-Ca2+ spark frequency (CaSpF) after addition of either PF-01247324 or the CaMKIIδ inhibitor AIP in failing human and murine ventricular cardiomyocytes. When PF-01247324 and AIP were added together, the decrease in INaL integral and CaSpF was comparable to PF-01247324 alone in human failing cardiomyocytes. Inhibition of NaV1.8 did not show an effect on Ca2+ transient amplitude or Ca2+ transient decay at different stimulation frequencies in CaMKIIδ TG cardiomyocytes.
Conclusion
Our results demonstrate the significance of both CaMKIIδ and NaV1.8 in INaL generation and their detrimental interaction. This data suggest that increased CaMKIIδ activity plays a substantial role for the activation of NaV1.8-mediated late sodium current and SR-Ca2+ leak.
Collapse
Affiliation(s)
- P Tirilomis
- University Medical Center of Gottingen (UMG), Gottingen, Germany
| | - S Ahmad
- University Hospital Regensburg, 2nd Department of Medicine, Regensburg, Germany
| | - P Bengel
- University Medical Center of Gottingen (UMG), Gottingen, Germany
| | - S Pabel
- University Hospital Regensburg, 2nd Department of Medicine, Regensburg, Germany
| | - L Maier
- University Hospital Regensburg, 2nd Department of Medicine, Regensburg, Germany
| | - G Hasenfuss
- University Medical Center of Gottingen (UMG), Gottingen, Germany
| | - N Dybkova
- University Medical Center of Gottingen (UMG), Gottingen, Germany
| | - S T Sossalla
- University Hospital Regensburg, 2nd Department of Medicine, Regensburg, Germany
| |
Collapse
|
17
|
Maier L, Betteridge Z, Udvardi A, Schmid-Simbeck M, Seeber A, Volc-Platzer B. Paraneoplastic Dermatomyositis: relevance of myositis-specific autoantibodies in a small cohort. J Eur Acad Dermatol Venereol 2019; 34:e50-e51. [PMID: 31429503 DOI: 10.1111/jdv.15897] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- L Maier
- Department of Dermatology, Sozialmedizinisches Zentrum Ost- Donauspital, Vienna, Austria.,Medical Research Society Donaustadt, Vienna, Austria
| | - Z Betteridge
- Department of Pharmacy and Pharmacology, University of Bath, Bath, UK
| | - A Udvardi
- Department of Dermatology, Sozialmedizinisches Zentrum Ost- Donauspital, Vienna, Austria.,Medical Research Society Donaustadt, Vienna, Austria
| | - M Schmid-Simbeck
- Department of Dermatology, Sozialmedizinisches Zentrum Ost- Donauspital, Vienna, Austria.,Medical Research Society Donaustadt, Vienna, Austria
| | - A Seeber
- Department of Dermatology, Sozialmedizinisches Zentrum Ost- Donauspital, Vienna, Austria.,Medical Research Society Donaustadt, Vienna, Austria
| | - B Volc-Platzer
- Department of Dermatology, Sozialmedizinisches Zentrum Ost- Donauspital, Vienna, Austria.,Medical Research Society Donaustadt, Vienna, Austria
| |
Collapse
|
18
|
Adamczewski-Musch J, Arnold O, Atomssa ET, Behnke C, Belounnas A, Belyaev A, Berger-Chen JC, Biernat J, Blanco A, Blume C, Böhmer M, Chernenko S, Chlad L, Chudoba P, Ciepał I, Deveaux C, Dittert D, Dreyer J, Epple E, Fabbietti L, Fateev O, Fonte P, Franco C, Friese J, Fröhlich I, Galatyuk T, Garzón JA, Gernhäuser R, Golubeva M, Greifenhagen R, Guber F, Gumberidze M, Harabasz S, Heinz T, Hennino T, Höhne C, Holzmann R, Ierusalimov A, Ivashkin A, Kämpfer B, Kardan B, Koenig I, Koenig W, Kolb BW, Korcyl G, Kornakov G, Kornas F, Kotte R, Kuboś J, Kugler A, Kunz T, Kurepin A, Kurilkin A, Kurilkin P, Ladygin V, Lalik R, Lapidus K, Lebedev A, Linev S, Lopes L, Lorenz M, Mahmoud T, Maier L, Malige A, Markert J, Maurus S, Metag V, Michel J, Mihaylov DM, Mikhaylov V, Morozov S, Müntz C, Münzer R, Naumann L, Nowakowski K, Parpottas Y, Pechenov V, Pechenova O, Petukhov O, Pietraszko J, Prozorov AP, Przygoda W, Ramstein B, Rathod N, Reshetin A, Rodriguez-Ramos P, Rost A, Sadovsky A, Salabura P, Scheib T, Schmidt-Sommerfeld K, Schuldes H, Schwab E, Scozzi F, Seck F, Sellheim P, Siebenson J, Silva L, Smyrski J, Spataro S, Spies S, Ströbele H, Stroth J, Strzempek P, Sturm C, Svoboda O, Szala M, Tlusty P, Traxler M, Tsertos H, Ungethüm C, Vázquez Doce O, Wagner V, Wendisch C, Wiebusch MG, Wirth J, Wójcik D, Zanevsky Y, Zumbruch P, Curceanu C, Piscicchia K, Scordo A. Strong Absorption of Hadrons with Hidden and Open Strangeness in Nuclear Matter. Phys Rev Lett 2019; 123:022002. [PMID: 31386541 DOI: 10.1103/physrevlett.123.022002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/18/2018] [Revised: 04/29/2019] [Indexed: 06/10/2023]
Abstract
We present the first observation of K^{-} and ϕ absorption within nuclear matter by means of π^{-}-induced reactions on C and W targets at an incident beam momentum of 1.7 GeV/c studied with HADES at SIS18/GSI. The double ratio (K^{-}/K^{+})_{W}/(K^{-}/K^{+})_{C} is found to be 0.319±0.009(stat)_{-0.012}^{+0.014}(syst) indicating a larger absorption of K^{-} in heavier targets as compared to lighter ones. The measured ϕ/K^{-} ratios in π^{-}+C and π^{-}+W reactions within the HADES acceptance are found to be equal to 0.55±0.04(stat)_{-0.07}^{+0.06}(syst) and to 0.63±0.06(stat)_{-0.11}^{+0.11}(syst), respectively. The similar ratios measured in the two different reactions demonstrate for the first time experimentally that the dynamics of the ϕ meson in nuclear medium is strongly coupled to the K^{-} dynamics. The large difference in the ϕ production off C and W nuclei is discussed in terms of a strong ϕN in-medium coupling. These results are relevant for the description of heavy-ion collisions and the structure of neutron stars.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - C Curceanu
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
| | - K Piscicchia
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
- CENTRO FERMI - Museo Storico della Fisica e Centro Studi e Ricerche "Enrico Fermi", 00184 Rome, Italy
| | - A Scordo
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
| |
Collapse
|
19
|
|
20
|
Stiebritz L, Sandhaus T, Maier L, Moschovas A, Doenst T, Steinert M. Current Surgical Treatment Strategies of Pleural Empyema. Thorac Cardiovasc Surg 2019. [DOI: 10.1055/s-0039-1678910] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Affiliation(s)
- L. Stiebritz
- Department of Cardiothoracic Surgery, University Hospital, Friedrich-Schiller-University Jena, Jena, Germany
| | - T. Sandhaus
- Department of Cardiothoracic Surgery, University Hospital, Friedrich-Schiller-University Jena, Jena, Germany
| | - L. Maier
- Department of Cardiothoracic Surgery, University Hospital, Friedrich-Schiller-University Jena, Jena, Germany
| | - A. Moschovas
- Department of Cardiothoracic Surgery, University Hospital, Friedrich-Schiller-University Jena, Jena, Germany
| | - T. Doenst
- Department of Cardiothoracic Surgery, University Hospital, Friedrich-Schiller-University Jena, Jena, Germany
| | - M. Steinert
- Department of Cardiothoracic Surgery, University Hospital, Friedrich-Schiller-University Jena, Jena, Germany
| |
Collapse
|
21
|
Zeller J, Krueger C, Lamounier-Zepter V, Fenk S, Strack C, Mohr M, Loew T, Schmitz G, Maier L, Fischer M, Baessler A. 108The adipo-fibrokine Activin A is associated with metabolic abnormalities and left ventricular diastolic dysfunction. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy564.108] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- J Zeller
- University Hospital Regensburg, Internal Medicine II, Regensburg, Germany
| | - C Krueger
- University Hospital Regensburg, Internal Medicine II, Regensburg, Germany
| | | | - S Fenk
- University Hospital Regensburg, Internal Medicine II, Regensburg, Germany
| | - C Strack
- University Hospital Regensburg, Internal Medicine II, Regensburg, Germany
| | - M Mohr
- University Hospital Regensburg, Internal Medicine II, Regensburg, Germany
| | - T Loew
- University Hospital Regensburg, Department of Psychosomatics, Regensburg, Germany
| | - G Schmitz
- University Hospital Regensburg, Central Institute for Clinical Chemistry and Laboratory Medicine, Regensburg, Germany
| | - L Maier
- University Hospital Regensburg, Internal Medicine II, Regensburg, Germany
| | - M Fischer
- University Hospital Regensburg, Internal Medicine II, Regensburg, Germany
| | - A Baessler
- University Hospital Regensburg, Internal Medicine II, Regensburg, Germany
| |
Collapse
|
22
|
Pabel S, Bollenberg H, Bengel P, Tirilomis P, Mustroph J, Wagner S, Fischer T, Streckfuss-Boemeke K, Maier L, Hasenfuss G, Hamdani N, Sossalla S. P1509Empagliflozin directly improves diastolic function in human heart failure. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy565.p1509] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- S Pabel
- University Hospital Regensburg, Internal Medicine II, Heart Center, Regensburg, Germany
| | - H Bollenberg
- University Medical Center Gottingen (UMG), Dept. of Cardiology and Pneumology, Heart Center, Gottingen, Germany
| | - P Bengel
- University Medical Center Gottingen (UMG), Dept. of Cardiology and Pneumology, Heart Center, Gottingen, Germany
| | - P Tirilomis
- University Medical Center Gottingen (UMG), Dept. of Cardiology and Pneumology, Heart Center, Gottingen, Germany
| | - J Mustroph
- University Hospital Regensburg, Internal Medicine II, Heart Center, Regensburg, Germany
| | - S Wagner
- University Hospital Regensburg, Internal Medicine II, Heart Center, Regensburg, Germany
| | - T Fischer
- University Medical Center Gottingen (UMG), Dept. of Cardiology and Pneumology, Heart Center, Gottingen, Germany
| | - K Streckfuss-Boemeke
- University Medical Center Gottingen (UMG), Dept. of Cardiology and Pneumology, Heart Center, Gottingen, Germany
| | - L Maier
- University Hospital Regensburg, Internal Medicine II, Heart Center, Regensburg, Germany
| | - G Hasenfuss
- University Medical Center Gottingen (UMG), Dept. of Cardiology and Pneumology, Heart Center, Gottingen, Germany
| | - N Hamdani
- Ruhr University Bochum (RUB), Department of Cardiovascular Physiology, Bochum, Germany
| | - S Sossalla
- University Hospital Regensburg, Internal Medicine II, Heart Center, Regensburg, Germany
| |
Collapse
|
23
|
Dybkova N, Ahmad S, Pabel S, Hartmann N, Tirilomis P, Streckfuss K, Maier L, Frey N, Hasenfuss G, Sossalla S. P4711Contribution of neuronal sodium channel isoform Nav1.8 to enhanced proarrhythmic late sodium current in the human failing heart. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p4711] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- N Dybkova
- Dept. Cardiology, University Medical Center, Goettingen, Germany
| | - S Ahmad
- Dept. Cardiology, University Medical Center, Goettingen, Germany
| | - S Pabel
- University, Dept. of Clinic and Polyclinic for Internal Medicine, Regensburg, Germany
| | - N Hartmann
- Dept. Cardiology, University Medical Center, Goettingen, Germany
| | - P Tirilomis
- Dept. Cardiology, University Medical Center, Goettingen, Germany
| | - K Streckfuss
- Dept. Cardiology, University Medical Center, Goettingen, Germany
| | - L Maier
- University, Dept. of Clinic and Polyclinic for Internal Medicine, Regensburg, Germany
| | - N Frey
- University Medical Center of Schleswig-Holstein, Dept. of Internal Medicine III (Cardiology and Angiology), Kiel, Germany
| | - G Hasenfuss
- Dept. Cardiology, University Medical Center, Goettingen, Germany
| | - S Sossalla
- University, Dept. of Clinic and Polyclinic for Internal Medicine, Regensburg, Germany
| |
Collapse
|
24
|
Abstract
This paper presents the concepts of an open software tool (CaRMeN) that can be used to rapidly analyse and derive models, in particular chemical kinetics. The software automates the workflow of comparing model vs. experiment, which must currently be done manually and is thus a time-consuming and error-prone task. The capabilities of the software are illustrated through a case study. Experimental data for the conversion of methane over rhodium catalysts in a wide range of conditions and experimental setups are numerically simulated using five different mechanisms from the literature. The applicability of the mechanisms as well as differences between flow and diffusion models are evaluated. The results show that no single mechanism reliably predicts the chemical conversions of all of the experiments. Although the software was initially developed for chemical kinetics applications, it can also be extended to run any simulation code, and can therefore be applied in other scenarios.
Collapse
Affiliation(s)
- H Gossler
- Institute for Chemical Technology and Polymer Chemistry, Karlsruhe Institute of Technology (KIT), Germany.
| | | | | | | | | |
Collapse
|
25
|
Steinert M, Moulla Y, Maier L, Gonzalez-Lopez D, Moschovas A, Sandhaus T, Doenst T. Uniportal Video-Assisted Thoracic Surgery, Feasibility and Ability. Thorac Cardiovasc Surg 2018. [DOI: 10.1055/s-0038-1627906] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- M. Steinert
- Department of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, Jena, Germany
| | - Y. Moulla
- Department of Visceral, Transplant, Thoracic and Vascular Surgery, University Hospital Leipzig, Leipizig, Germany
| | - L. Maier
- Department of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, Jena, Germany
| | - D. Gonzalez-Lopez
- Department of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, Jena, Germany
| | - A. Moschovas
- Department of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, Jena, Germany
| | - T. Sandhaus
- Department of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, Jena, Germany
| | - T. Doenst
- Department of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, Jena, Germany
| |
Collapse
|
26
|
Sandhaus T, Maier L, Gonzalez-Lopez D, Moschovas A, Diab M, Färber G, Doenst T, Steinert M. Different Indications for Hyperthermic Intrathoracic Chemotherapy Perfusion (HITHOC). Thorac Cardiovasc Surg 2018. [DOI: 10.1055/s-0038-1627904] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- T. Sandhaus
- Department of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, Jena, Germany
| | - L. Maier
- Department of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, Jena, Germany
| | - D. Gonzalez-Lopez
- Department of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, Jena, Germany
| | - A. Moschovas
- Department of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, Jena, Germany
| | - M. Diab
- Department of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, Jena, Germany
| | - G. Färber
- Department of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, Jena, Germany
| | - T. Doenst
- Department of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, Jena, Germany
| | - M. Steinert
- Department of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, Jena, Germany
| |
Collapse
|
27
|
Maier L, Sandhaus T, Doenst T, Steinert M. Initial Experiences with Robotic-assisted Anatomic Lung Resections at a University Hospital. Thorac Cardiovasc Surg 2018. [DOI: 10.1055/s-0038-1627955] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- L. Maier
- Klinik für Herz- und Thoraxchirurgie, Universitätsklinikum Jena, Jena, Germany
| | - T. Sandhaus
- Klinik für Herz- und Thoraxchirurgie, Universitätsklinikum Jena, Jena, Germany
| | - T. Doenst
- Klinik für Herz- und Thoraxchirurgie, Universitätsklinikum Jena, Jena, Germany
| | - M. Steinert
- Klinik für Herz- und Thoraxchirurgie, Universitätsklinikum Jena, Jena, Germany
| |
Collapse
|
28
|
Moschovas A, Sandhaus T, Maier L, Gonzalez-Lopez D, Doenst T, Steinert M. Idiopathic Fibrosing Mediastinitis: A Case Report. Thorac Cardiovasc Surg 2018. [DOI: 10.1055/s-0037-1616860] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- A. Moschovas
- Department of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, Jena, Germany
| | - T. Sandhaus
- Department of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, Jena, Germany
| | - L. Maier
- Department of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, Jena, Germany
| | - D. Gonzalez-Lopez
- Department of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, Jena, Germany
| | - T. Doenst
- Department of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, Jena, Germany
| | - M. Steinert
- Department of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, Jena, Germany
| |
Collapse
|
29
|
Aldawood S, Thirolf P, Miani A, Böhmer M, Dedes G, Gernhäuser R, Lang C, Liprandi S, Maier L, Marinšek T, Mayerhofer M, Schaart D, Lozano IV, Parodi K. Development of a Compton camera for prompt-gamma medical imaging. Radiat Phys Chem Oxf Engl 1993 2017. [DOI: 10.1016/j.radphyschem.2017.01.024] [Citation(s) in RCA: 35] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
30
|
Maier L, Udvardi A, Hertl M, Eming R, Schmidt E, Zillikens D, Volc-Platzer B. Paraneoplastic pemphigus with anti-BP180 autoantibodies and Castleman disease. Br J Dermatol 2017; 176:824-826. [PMID: 27436786 DOI: 10.1111/bjd.14877] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Affiliation(s)
- L Maier
- Department of Dermatology, Sozialmedizinisches Zentrum Ost Donauspital, Vienna, Austria
- Medical Research Society Donaustadt, Vienna, Austria
| | - A Udvardi
- Department of Dermatology, Sozialmedizinisches Zentrum Ost Donauspital, Vienna, Austria
- Medical Research Society Donaustadt, Vienna, Austria
| | - M Hertl
- Department of Dermatology and Allergology, Philipps-Universität Marburg, Marburg, Germany
| | - R Eming
- Department of Dermatology and Allergology, Philipps-Universität Marburg, Marburg, Germany
| | - E Schmidt
- Department of Dermatology, University of Lübeck, Lübeck, Germany
- Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany
| | - D Zillikens
- Department of Dermatology, University of Lübeck, Lübeck, Germany
| | - B Volc-Platzer
- Department of Dermatology, Sozialmedizinisches Zentrum Ost Donauspital, Vienna, Austria
- Medical Research Society Donaustadt, Vienna, Austria
| |
Collapse
|
31
|
Sandhaus T, Maier L, Gonzalez-Lopez D, Doenst T, Steinert M. Initial Experience in Robot-Assisted Thoracic Surgery (RATS) at a University Center. Thorac Cardiovasc Surg 2017. [DOI: 10.1055/s-0037-1598680] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- T. Sandhaus
- Department of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, Jena, Germany
| | - L. Maier
- Department of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, Jena, Germany
| | - D. Gonzalez-Lopez
- Department of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, Jena, Germany
| | - T. Doenst
- Department of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, Jena, Germany
| | - M. Steinert
- Department of Cardiothoracic Surgery, Friedrich-Schiller-University Jena, Jena, Germany
| |
Collapse
|
32
|
Reuschel E, Baessler A, Stöllberger C, Finsterer J, Maier L, Fischer M, Poschenrieder F, Heissenhuber F, Kurzidim K, Schepp CP, Badelt G, Seelbach-Göbel B. Interdisciplinary management of left ventricular hypertrabeculation/noncompaction during pregnancy with a wearable defibrillator. Int J Cardiol 2016; 223:154-158. [PMID: 27537747 DOI: 10.1016/j.ijcard.2016.08.097] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/03/2016] [Accepted: 08/05/2016] [Indexed: 01/07/2023]
Affiliation(s)
- E Reuschel
- Klinik für Gynaekologie und Geburtshilfe, Krankenhaus Barmherzige Brüder Regensburg, Germany.
| | - A Baessler
- Universitäres Herzzentrum Regensburg, Regensburg, Germany.
| | | | - J Finsterer
- Institut für Röntgendiagnostik, Universitätsklinikum Regensburg, Germany
| | - L Maier
- Universitäres Herzzentrum Regensburg, Regensburg, Germany
| | - M Fischer
- Universitäres Herzzentrum Regensburg, Regensburg, Germany
| | - F Poschenrieder
- Institut für Röntgendiagnostik, Universitätsklinikum Regensburg, Germany
| | - F Heissenhuber
- Klinik für Herzrhythmusstörungen, Krankenhaus Barmherzige Brüder Regensburg, Germany
| | - K Kurzidim
- Klinik für Herzrhythmusstörungen, Krankenhaus Barmherzige Brüder Regensburg, Germany
| | - C P Schepp
- Klinik für Anästhesiologie, Krankenhaus Barmherzige Brüder Regensburg, Germany
| | - G Badelt
- Klinik für Anästhesiologie, Krankenhaus Barmherzige Brüder Regensburg, Germany
| | - B Seelbach-Göbel
- Klinik für Gynaekologie und Geburtshilfe, Krankenhaus Barmherzige Brüder Regensburg, Germany
| |
Collapse
|
33
|
Caballero-Folch R, Domingo-Pardo C, Agramunt J, Algora A, Ameil F, Arcones A, Ayyad Y, Benlliure J, Borzov IN, Bowry M, Calviño F, Cano-Ott D, Cortés G, Davinson T, Dillmann I, Estrade A, Evdokimov A, Faestermann T, Farinon F, Galaviz D, García AR, Geissel H, Gelletly W, Gernhäuser R, Gómez-Hornillos MB, Guerrero C, Heil M, Hinke C, Knöbel R, Kojouharov I, Kurcewicz J, Kurz N, Litvinov YA, Maier L, Marganiec J, Marketin T, Marta M, Martínez T, Martínez-Pinedo G, Montes F, Mukha I, Napoli DR, Nociforo C, Paradela C, Pietri S, Podolyák Z, Prochazka A, Rice S, Riego A, Rubio B, Schaffner H, Scheidenberger C, Smith K, Sokol E, Steiger K, Sun B, Taín JL, Takechi M, Testov D, Weick H, Wilson E, Winfield JS, Wood R, Woods P, Yeremin A. First Measurement of Several β-Delayed Neutron Emitting Isotopes Beyond N=126. Phys Rev Lett 2016; 117:012501. [PMID: 27419564 DOI: 10.1103/physrevlett.117.012501] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/04/2015] [Indexed: 06/06/2023]
Abstract
The β-delayed neutron emission probabilities of neutron rich Hg and Tl nuclei have been measured together with β-decay half-lives for 20 isotopes of Au, Hg, Tl, Pb, and Bi in the mass region N≳126. These are the heaviest species where neutron emission has been observed so far. These measurements provide key information to evaluate the performance of nuclear microscopic and phenomenological models in reproducing the high-energy part of the β-decay strength distribution. This provides important constraints on global theoretical models currently used in r-process nucleosynthesis.
Collapse
Affiliation(s)
- R Caballero-Folch
- INTE-DFEN, Universitat Politècnica de Catalunya, E-08028 Barcelona, Spain
- TRIUMF, Vancouver, British Columbia V6T2A3, Canada
| | | | - J Agramunt
- IFIC, CSIC-University of Valencia, E-46071 Valencia, Spain
| | - A Algora
- IFIC, CSIC-University of Valencia, E-46071 Valencia, Spain
- Institute of Nuclear Research of the Hungarian Academy of Sciences, Debrecen H-4001, Hungary
| | - F Ameil
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
| | - A Arcones
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
| | - Y Ayyad
- Universidade de Santiago de Compostela, E-15782 Santiago de Compostela, Spain
| | - J Benlliure
- Universidade de Santiago de Compostela, E-15782 Santiago de Compostela, Spain
| | - I N Borzov
- National Research Centre "Kurchatov Institute", 123182 Moscow, Russia
- Bogolubov Laboratory, Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - M Bowry
- Department of Physics, University of Surrey, Guildford GU2 7XH, United Kingdom
| | - F Calviño
- INTE-DFEN, Universitat Politècnica de Catalunya, E-08028 Barcelona, Spain
| | | | - G Cortés
- INTE-DFEN, Universitat Politècnica de Catalunya, E-08028 Barcelona, Spain
| | - T Davinson
- University of Edinburgh, EH9 3JZ Edinburgh, United Kingdom
| | - I Dillmann
- TRIUMF, Vancouver, British Columbia V6T2A3, Canada
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
- Justus-Liebig Universität Giessen, D-35392 Giessen, Germany
| | - A Estrade
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
- St. Mary's University, Halifax, B3H 3C3 Nova Scotia, Canada
| | - A Evdokimov
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
- Justus-Liebig Universität Giessen, D-35392 Giessen, Germany
| | - T Faestermann
- Physik Department E12, Technische Universität München, D-85748 Garching, Germany
| | - F Farinon
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
| | - D Galaviz
- Centro de Fisica Nuclear da Universidade de Lisboa, 169-003 Lisboa, Portugal
| | | | - H Geissel
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
- Justus-Liebig Universität Giessen, D-35392 Giessen, Germany
| | - W Gelletly
- Department of Physics, University of Surrey, Guildford GU2 7XH, United Kingdom
| | - R Gernhäuser
- Physik Department E12, Technische Universität München, D-85748 Garching, Germany
| | | | - C Guerrero
- CERN Physics Department, CH-1211 Geneve, Switzerland
- Universidad de Sevilla, 41080 Seville, Spain
| | - M Heil
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
| | - C Hinke
- Physik Department E12, Technische Universität München, D-85748 Garching, Germany
| | - R Knöbel
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
| | - I Kojouharov
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
| | - J Kurcewicz
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
| | - N Kurz
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
| | - Yu A Litvinov
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
| | - L Maier
- Physik Department E12, Technische Universität München, D-85748 Garching, Germany
| | - J Marganiec
- ExtreMe Matter Institute, 64291 Darmstadt, Germany
| | - T Marketin
- Department of Physics, Faculty of Science, University of Zagreb, 10000 Zagreb, Croatia
| | - M Marta
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
- Justus-Liebig Universität Giessen, D-35392 Giessen, Germany
| | | | - G Martínez-Pinedo
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
- Institut für Kernphysik (Theoriezentrum), Technische Universität Darmstadt, 64289 Darmstadt, Germany
| | - F Montes
- National Superconducting Cyclotron Laboratory, Michigan State University, East Lansing, Michigan 48824, USA
- Joint Institute for Nuclear Astrophysics, Michigan State University, East Lansing, Michigan 48824, USA
| | - I Mukha
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
| | - D R Napoli
- Instituto Nazionale di Fisica Nucleare, Laboratori Nazionali di Legnaro, Legnaro I-35020, Italy
| | - C Nociforo
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
| | - C Paradela
- Universidade de Santiago de Compostela, E-15782 Santiago de Compostela, Spain
| | - S Pietri
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
| | - Zs Podolyák
- Department of Physics, University of Surrey, Guildford GU2 7XH, United Kingdom
| | - A Prochazka
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
| | - S Rice
- Department of Physics, University of Surrey, Guildford GU2 7XH, United Kingdom
| | - A Riego
- INTE-DFEN, Universitat Politècnica de Catalunya, E-08028 Barcelona, Spain
| | - B Rubio
- IFIC, CSIC-University of Valencia, E-46071 Valencia, Spain
| | - H Schaffner
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
| | - Ch Scheidenberger
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
- Justus-Liebig Universität Giessen, D-35392 Giessen, Germany
| | - K Smith
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
- National Superconducting Cyclotron Laboratory, Michigan State University, East Lansing, Michigan 48824, USA
- Joint Institute for Nuclear Astrophysics, Michigan State University, East Lansing, Michigan 48824, USA
- University of Notre Dame, South Bend, Indiana 46556, USA
- University of Tennessee, Knoxville, Knoxville, Tennessee 37996, USA
| | - E Sokol
- Flerov Laboratory, Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - K Steiger
- Physik Department E12, Technische Universität München, D-85748 Garching, Germany
| | - B Sun
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
| | - J L Taín
- IFIC, CSIC-University of Valencia, E-46071 Valencia, Spain
| | - M Takechi
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
| | - D Testov
- Flerov Laboratory, Joint Institute for Nuclear Research, 141980 Dubna, Russia
- Institut de Physique Nucléaire d'Orsay, Orsay F-91405, France
| | - H Weick
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
| | - E Wilson
- Department of Physics, University of Surrey, Guildford GU2 7XH, United Kingdom
| | - J S Winfield
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
| | - R Wood
- Department of Physics, University of Surrey, Guildford GU2 7XH, United Kingdom
| | - P Woods
- University of Edinburgh, EH9 3JZ Edinburgh, United Kingdom
| | - A Yeremin
- Flerov Laboratory, Joint Institute for Nuclear Research, 141980 Dubna, Russia
| |
Collapse
|
34
|
Thirolf P, Aldawood S, Böhmer M, Bortfeldt J, Castelhano I, Dedes G, Fiedler F, Gernhäuser R, Golnik C, Helmbrecht S, Hueso-González F, Kolff HV, Kormoll T, Lang C, Liprandi S, Lutter R, Marinšek T, Maier L, Pausch G, Petzoldt J, Römer K, Schaart D, Parodi K. A Compton camera prototype for prompt gamma medical imaging. EPJ Web of Conferences 2016. [DOI: 10.1051/epjconf/201611705005] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
35
|
Aldawood S, Bortfeldt J, Böhmer M, Castelhano I, Dedes G, Enghardt W, Fiedler F, Gernhäuser R, Golnik C, Helmbrecht S, Hueso-González F, Kolff H, Kormoll T, Lang C, Liprandi S, Lutter R, Maier L, Marinšek T, Pausch G, Petzoldt J, Pocevicius M, Römer K, Valencia Lozano I, Schaart D, Parodi K, Thirolf P. Commissioning of a Compton camera for ion beam range verification via prompt γ detection using low-energy and clinical particle beams. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)30005-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
36
|
Brand M, Schwiede M, Trappe HJ, Christ M, Maier L, Luchner A, Jungbauer CG. Established renal markers for diagnosis and prognosis in acutely decompensated heart failure. Intensive Care Med Exp 2015. [PMCID: PMC4797905 DOI: 10.1186/2197-425x-3-s1-a259] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
37
|
Agakishiev G, Arnold O, Balanda A, Belver D, Belyaev AV, Berger-Chen JC, Blanco A, Böhmer M, Boyard JL, Cabanelas P, Chernenko S, Dybczak A, Epple E, Fabbietti L, Fateev OV, Finocchiaro P, Fonte P, Friese J, Fröhlich I, Galatyuk T, Garzón JA, Gernhäuser R, Göbel K, Golubeva M, González-Díaz D, Guber F, Gumberidze M, Heinz T, Hennino T, Holzmann R, Ierusalimov A, Iori I, Ivashkin A, Jurkovic M, Kämpfer B, Karavicheva T, Koenig I, Koenig W, Kolb BW, Kornakov G, Kotte R, Krása A, Krizek F, Krücken R, Kuc H, Kühn W, Kugler A, Kurepin A, Ladygin V, Lalik R, Lang S, Lapidus K, Lebedev A, Liu T, Lopes L, Lorenz M, Maier L, Mangiarotti A, Markert J, Metag V, Michalska B, Michel J, Müntz C, Müntzer R, Naumann L, Pachmayer YC, Palka M, Parpottas Y, Pechenov V, Pechenova O, Pietraszko J, Przygoda W, Ramstein B, Reshetin A, Rustamov A, Sadovsky A, Salabura P, Schmah A, Schwab E, Siebenson J, Sobolev YG, Spataro S, Spruck B, Ströbele H, Stroth J, Sturm C, Tarantola A, Teilab K, Tlusty P, Traxler M, Trebacz R, Tsertos H, Vasiliev T, Wagner V, Weber M, Wendisch C, Wüstenfeld J, Yurevich S, Zanevsky YV. Subthreshold Ξ^{-} production in collisions of p(3.5 GeV)+Nb. Phys Rev Lett 2015; 114:212301. [PMID: 26066429 DOI: 10.1103/physrevlett.114.212301] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/16/2015] [Indexed: 06/04/2023]
Abstract
Results on the production of the double strange cascade hyperon Ξ^{-} are reported for collisions of p(3.5 GeV)+Nb, studied with the High Acceptance Di-Electron Spectrometer (HADES) at SIS18 at GSI Helmholtzzentrum for Heavy-Ion Research, Darmstadt. For the first time, subthreshold Ξ^{-} production is observed in proton-nucleus interactions. Assuming a Ξ^{-} phase-space distribution similar to that of Λ hyperons, the production probability amounts to P_{Ξ^{-}}=[2.0±0.4(stat)±0.3(norm)±0.6(syst)]×10^{-4} resulting in a Ξ^{-}/(Λ+Σ^{0}) ratio of P_{Ξ^{-}}/P_{Λ+Σ^{0}}=[1.2±0.3(stat)±0.4(syst)]×10^{-2}. Available model predictions are significantly lower than the measured Ξ^{-} yield.
Collapse
Affiliation(s)
- G Agakishiev
- Joint Institute of Nuclear Research, 141980 Dubna, Russia
| | - O Arnold
- Excellence Cluster "Origin and Structure of the Universe," 85748 Garching, Germany
| | - A Balanda
- Smoluchowski Institute of Physics, Jagiellonian University of Cracow, 30-059 Kraków, Poland
| | - D Belver
- LabCAF Facultad de Física, Universidade de Santiago de Compostela, 15706 Santiago de Compostela, Spain
| | - A V Belyaev
- Joint Institute of Nuclear Research, 141980 Dubna, Russia
| | - J C Berger-Chen
- Excellence Cluster "Origin and Structure of the Universe," 85748 Garching, Germany
| | - A Blanco
- LIP-Laboratório de Instrumentação e Física Experimental de Partículas, 3004-516 Coimbra, Portugal
| | - M Böhmer
- Physik Department E12, Technische Universität München, 85748 Garching, Germany
| | - J L Boyard
- Institut de Physique Nucléaire (UMR 8608), CNRS/IN2P3 - Université Paris Sud, F-91406 Orsay Cedex, France
| | - P Cabanelas
- LabCAF Facultad de Física, Universidade de Santiago de Compostela, 15706 Santiago de Compostela, Spain
| | - S Chernenko
- Joint Institute of Nuclear Research, 141980 Dubna, Russia
| | - A Dybczak
- Smoluchowski Institute of Physics, Jagiellonian University of Cracow, 30-059 Kraków, Poland
| | - E Epple
- Excellence Cluster "Origin and Structure of the Universe," 85748 Garching, Germany
| | - L Fabbietti
- Excellence Cluster "Origin and Structure of the Universe," 85748 Garching, Germany
| | - O V Fateev
- Joint Institute of Nuclear Research, 141980 Dubna, Russia
| | - P Finocchiaro
- Instituto Nazionale di Fisica Nucleare - Laboratori Nazionali del Sud, 95125 Catania, Italy
| | - P Fonte
- LIP-Laboratório de Instrumentação e Física Experimental de Partículas, 3004-516 Coimbra, Portugal
| | - J Friese
- Physik Department E12, Technische Universität München, 85748 Garching, Germany
| | - I Fröhlich
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität, 60438 Frankfurt, Germany
| | - T Galatyuk
- Technische Universität Darmstadt, 64289 Darmstadt, Germany
| | - J A Garzón
- LabCAF Facultad de Física, Universidade de Santiago de Compostela, 15706 Santiago de Compostela, Spain
| | - R Gernhäuser
- Physik Department E12, Technische Universität München, 85748 Garching, Germany
| | - K Göbel
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität, 60438 Frankfurt, Germany
| | - M Golubeva
- Institute for Nuclear Research, Russian Academy of Science, 117312 Moscow, Russia
| | | | - F Guber
- Institute for Nuclear Research, Russian Academy of Science, 117312 Moscow, Russia
| | - M Gumberidze
- Technische Universität Darmstadt, 64289 Darmstadt, Germany
- Institut de Physique Nucléaire (UMR 8608), CNRS/IN2P3 - Université Paris Sud, F-91406 Orsay Cedex, France
| | - T Heinz
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - T Hennino
- Institut de Physique Nucléaire (UMR 8608), CNRS/IN2P3 - Université Paris Sud, F-91406 Orsay Cedex, France
| | - R Holzmann
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - A Ierusalimov
- Joint Institute of Nuclear Research, 141980 Dubna, Russia
| | - I Iori
- Istituto Nazionale di Fisica Nucleare, Sezione di Milano, 20133 Milano, Italy
| | - A Ivashkin
- Institute for Nuclear Research, Russian Academy of Science, 117312 Moscow, Russia
| | - M Jurkovic
- Physik Department E12, Technische Universität München, 85748 Garching, Germany
| | - B Kämpfer
- Institut für Strahlenphysik, Helmholtz-Zentrum Dresden-Rossendorf, 01328 Dresden, Germany
| | - T Karavicheva
- Institute for Nuclear Research, Russian Academy of Science, 117312 Moscow, Russia
| | - I Koenig
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - W Koenig
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - B W Kolb
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - G Kornakov
- LabCAF Facultad de Física, Universidade de Santiago de Compostela, 15706 Santiago de Compostela, Spain
| | - R Kotte
- Institut für Strahlenphysik, Helmholtz-Zentrum Dresden-Rossendorf, 01328 Dresden, Germany
| | - A Krása
- Nuclear Physics Institute, Academy of Sciences of Czech Republic, 25068 Rez, Czech Republic
| | - F Krizek
- Nuclear Physics Institute, Academy of Sciences of Czech Republic, 25068 Rez, Czech Republic
| | - R Krücken
- Physik Department E12, Technische Universität München, 85748 Garching, Germany
| | - H Kuc
- Smoluchowski Institute of Physics, Jagiellonian University of Cracow, 30-059 Kraków, Poland
- Institut de Physique Nucléaire (UMR 8608), CNRS/IN2P3 - Université Paris Sud, F-91406 Orsay Cedex, France
| | - W Kühn
- II. Physikalisches Institut, Justus Liebig Universität Giessen, 35392 Giessen, Germany
| | - A Kugler
- Nuclear Physics Institute, Academy of Sciences of Czech Republic, 25068 Rez, Czech Republic
| | - A Kurepin
- Institute for Nuclear Research, Russian Academy of Science, 117312 Moscow, Russia
| | - V Ladygin
- Joint Institute of Nuclear Research, 141980 Dubna, Russia
| | - R Lalik
- Excellence Cluster "Origin and Structure of the Universe," 85748 Garching, Germany
| | - S Lang
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - K Lapidus
- Excellence Cluster "Origin and Structure of the Universe," 85748 Garching, Germany
| | - A Lebedev
- Institute of Theoretical and Experimental Physics, 117218 Moscow, Russia
| | - T Liu
- Institut de Physique Nucléaire (UMR 8608), CNRS/IN2P3 - Université Paris Sud, F-91406 Orsay Cedex, France
| | - L Lopes
- LIP-Laboratório de Instrumentação e Física Experimental de Partículas, 3004-516 Coimbra, Portugal
| | - M Lorenz
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität, 60438 Frankfurt, Germany
| | - L Maier
- Physik Department E12, Technische Universität München, 85748 Garching, Germany
| | - A Mangiarotti
- LIP-Laboratório de Instrumentação e Física Experimental de Partículas, 3004-516 Coimbra, Portugal
| | - J Markert
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität, 60438 Frankfurt, Germany
| | - V Metag
- II. Physikalisches Institut, Justus Liebig Universität Giessen, 35392 Giessen, Germany
| | - B Michalska
- Smoluchowski Institute of Physics, Jagiellonian University of Cracow, 30-059 Kraków, Poland
| | - J Michel
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität, 60438 Frankfurt, Germany
| | - C Müntz
- Joint Institute of Nuclear Research, 141980 Dubna, Russia
| | - R Müntzer
- Excellence Cluster "Origin and Structure of the Universe," 85748 Garching, Germany
- Physik Department E12, Technische Universität München, 85748 Garching, Germany
| | - L Naumann
- Institut für Strahlenphysik, Helmholtz-Zentrum Dresden-Rossendorf, 01328 Dresden, Germany
| | - Y C Pachmayer
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität, 60438 Frankfurt, Germany
| | - M Palka
- Smoluchowski Institute of Physics, Jagiellonian University of Cracow, 30-059 Kraków, Poland
| | - Y Parpottas
- Department of Physics, University of Cyprus, 1678 Nicosia, Cyprus
| | - V Pechenov
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - O Pechenova
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität, 60438 Frankfurt, Germany
| | - J Pietraszko
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - W Przygoda
- Smoluchowski Institute of Physics, Jagiellonian University of Cracow, 30-059 Kraków, Poland
| | - B Ramstein
- Institut de Physique Nucléaire (UMR 8608), CNRS/IN2P3 - Université Paris Sud, F-91406 Orsay Cedex, France
| | - A Reshetin
- Institute for Nuclear Research, Russian Academy of Science, 117312 Moscow, Russia
| | - A Rustamov
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität, 60438 Frankfurt, Germany
| | - A Sadovsky
- Institute for Nuclear Research, Russian Academy of Science, 117312 Moscow, Russia
| | - P Salabura
- Smoluchowski Institute of Physics, Jagiellonian University of Cracow, 30-059 Kraków, Poland
| | - A Schmah
- Excellence Cluster "Origin and Structure of the Universe," 85748 Garching, Germany
| | - E Schwab
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - J Siebenson
- Excellence Cluster "Origin and Structure of the Universe," 85748 Garching, Germany
| | - Yu G Sobolev
- Nuclear Physics Institute, Academy of Sciences of Czech Republic, 25068 Rez, Czech Republic
| | - S Spataro
- II. Physikalisches Institut, Justus Liebig Universität Giessen, 35392 Giessen, Germany
| | - B Spruck
- II. Physikalisches Institut, Justus Liebig Universität Giessen, 35392 Giessen, Germany
| | - H Ströbele
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität, 60438 Frankfurt, Germany
| | - J Stroth
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität, 60438 Frankfurt, Germany
| | - C Sturm
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - A Tarantola
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität, 60438 Frankfurt, Germany
| | - K Teilab
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität, 60438 Frankfurt, Germany
| | - P Tlusty
- Nuclear Physics Institute, Academy of Sciences of Czech Republic, 25068 Rez, Czech Republic
| | - M Traxler
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - R Trebacz
- Smoluchowski Institute of Physics, Jagiellonian University of Cracow, 30-059 Kraków, Poland
| | - H Tsertos
- Department of Physics, University of Cyprus, 1678 Nicosia, Cyprus
| | - T Vasiliev
- Joint Institute of Nuclear Research, 141980 Dubna, Russia
| | - V Wagner
- Nuclear Physics Institute, Academy of Sciences of Czech Republic, 25068 Rez, Czech Republic
| | - M Weber
- Physik Department E12, Technische Universität München, 85748 Garching, Germany
| | - C Wendisch
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - J Wüstenfeld
- Institut für Strahlenphysik, Helmholtz-Zentrum Dresden-Rossendorf, 01328 Dresden, Germany
| | - S Yurevich
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - Y V Zanevsky
- Joint Institute of Nuclear Research, 141980 Dubna, Russia
| |
Collapse
|
38
|
Przygoda W, Adamczewski-Musch J, Arnold O, Atomssa E, Behnke C, Berger-Chen J, Biernat J, Blanco A, Blume C, Böhmer M, Bordalo P, Chernenko S, Deveaux C, Dybczak A, Epple E, Fabbietti L, Fateev O, Fonte P, Franco C, Friese J, Fröhlich I, Galatyuk T, Garzón JA, Gill K, Golubeva M, Guber F, Gumberidze M, Harabasz S, Hennino T, Hlavac S, Höhne C, Holzmann R, Ierusalimov A, Ivashkin A, Jurkovic M, Kämpfer B, Karavicheva T, Kardan B, Koenig I, Koenig W, Kolb BW, Korcyl G, Kornakov G, Kotte R, Krása A, Krebs E, Kuc H, Kugler A, Kunz T, Kurepin A, Kurilkin A, Kurilkin P, Ladygin V, Lalik R, Lapidus K, Lebedev A, Lopes L, Lorenz M, Mahmoud T, Maier L, Mangiarotti A, Markert J, Metag V, Michel J, Müntz C, Münzer R, Naumann L, Palka M, Parpottas Y, Pechenov V, Pechenova O, Petousis V, Pietraszko J, Ramstein B, Rehnisch L, Reshetin A, Rost A, Rustamov A, Sadovsky A, Salabura P, Scheib T, Schmidt-Sommerfeld K, Schuldes H, Sellheim P, Siebenson J, Silva L, Sobolev Y, Spataro S, Ströbele H, Stroth J, Strzempek P, Sturm C, Svoboda O, Tarantola A, Teilab K, Tlusty P, Traxler M, Tsertos H, Vasiliev T, Wagner V, Wendisch C, Wirth J, Wüstenfeld J, Zanevsky Y, Zumbruch P. Investigating hadronic resonances in pp interactions with HADES. EPJ Web of Conferences 2015. [DOI: 10.1051/epjconf/20159700024] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
39
|
Epple E, Adamczewski-Musch J, Arnold O, Atomssa E, Behnke C, Berger-Chen J, Biernat J, Blanco A, Blume C, Böhmer M, Bordalo P, Chernenko S, Deveaux C, Dybczak A, Fabbietti L, Fateev O, Fonte P, Franco C, Friese J, Fröhlich I, Galatyuk T, Garzón JA, Gill K, Golubeva M, Guber F, Gumberidze M, Harabasz S, Hennino T, Hlavac S, Höhne C, Holzmann R, Ierusalimov A, Ivashkin A, Jurkovic M, Kämpfer B, Karavicheva T, Kardan K, Koenig I, Koenig W, Kolb BW, Korcyl G, Kornakov G, Kotte R, Krása A, Krebs E, Kuc H, Kugler A, Kunz T, Kurepin A, Kurilkin A, Kurilkin P, Ladygin V, Lalik R, Lapidus K, Lebedev A, Lopes L, Lorenz M, Mahmoud T, Maier L, Mangiarotti A, Markert J, Metag V, Michel J, Müntz C, Münzer R, Naumann L, Palka M, Parpottas Y, Pechenov V, Pechenova O, Petousis V, Pietraszko J, Przygoda W, Ramstein B, Rehnisch L, Reshetin A, Rost A, Rustamov A, Sadovsky A, Salabura P, Scheib T, Schmidt-Sommerfeld K, Schuldes H, Sellheim P, Siebenson J, Silva L, Sobolev Y, Spataro S, Ströbele H, Stroth J, Strzempek P, Sturm C, Svoboda O, Tarantola A, Teilab K, Tlusty P, Traxler M, Tsertos H, Vasiliev T, Wagner V, Wendisch C, Wirth J, Wüstenfeld J, Zanevsky Y, Zumbruch P. Highlights of Resonance Measurements With HADES. EPJ Web of Conferences 2015. [DOI: 10.1051/epjconf/20159700015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
40
|
Gao BS, Najafi MA, Atanasov DR, Blaum K, Bosch F, Brandau C, Chen XC, Dillmann I, Dimopoulou C, Faestermann T, Geissel H, Gernhäuser R, Hillenbrand PM, Kovalenko O, Kozhuharov C, Litvinov SA, Litvinov YA, Maier L, Nolden F, Piotrowski J, Sanjari MS, Scheidenberger C, Spillmann U, Steck M, Stöhlker T, Trageser C, Tu XL, Weick H, Winckler N, Xu HS, Yamaguchi T, Yan XL, Zhang YH, Zhou XH. Radioactive decays of highly-charged ions. EPJ Web of Conferences 2015. [DOI: 10.1051/epjconf/20159305003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
41
|
Deutschmann O, Rischard J, Diehm C, Maier L. Untersuchung der Dehydrierung und der oxidativen Dehydrierung von n-Butan an Platin und V-basierten Katalysatoren in einem Zwei-Zonen-Wirbelschichtreaktor. CHEM-ING-TECH 2014. [DOI: 10.1002/cite.201450578] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
42
|
E Molina C, Barbet R, Jacquet E, Munoz Guijosa C, Baczko I, Maier L, Fischmeister R, Garnier A. P334Identification of suitable reference genes for gene expression studies in normal and pathological human heart tissues. Cardiovasc Res 2014. [DOI: 10.1093/cvr/cvu091.21] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
43
|
Streckfuss-Boemeke K, Fischer C, Stauske M, Perret A, Oezcelic C, Wagner S, Maier L, Hasenfuss G, Guan K. 266RBM20-dependent regulation of organized myofilament structure and titin splicing in induced pluripotent stem cell-derived cardiomyocytes from patients with dilative cardiomyopathy. Cardiovasc Res 2014. [DOI: 10.1093/cvr/cvu083.2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
44
|
Thirolf PG, Aldawood S, Boehmer M, Bortfeldt J, Castelhano I, Gernhaeuser R, v.d. Kolff H, Lang C, Maier L, Schaart DR, Parodi K. SU-E-J-46: Development of a Compton Camera Prototype for Online Range Verification of Laser-Accelerated Proton Beams. Med Phys 2014. [DOI: 10.1118/1.4888098] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
45
|
Thirolf P, Lang C, Aldawood S, v.d. Kolff H, Maier L, Schaart D, Parodi K. Development of a Compton Camera for Online Range Monitoring of Laser-Accelerated Proton Beams via Prompt-Gamma Detection. EPJ Web of Conferences 2014. [DOI: 10.1051/epjconf/20146611036] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
46
|
Kurilkin A, Arnold O, Atomssa ET, Behnke C, Belyaev A, Berger-Chen JC, Biernat J, Blanco A, Blume C, Böhmer M, Bordalo P, Chernenko S, Deveaux C, Dybczak A, Epple E, Fabbietti L, Fateev O, Fonte P, Franco C, Friese J, Fröhlich I, Galatyuk T, Garzón JA, Gill K, Golubeva M, González-Díaz D, Guber F, Gumberidze M, Harabasz S, Hennino T, Höhne C, Holzmann R, Ierusalimov A, Ivashkin A, Jurkovic M, Kämpfer B, Karavicheva T, Kardan K, Koenig I, Koenig W, Kolb BW, Korcyl G, Kornakov G, Kotte R, Krása A, Krebs E, Krizek F, Kuc H, Kugler A, Kunz T, Kurepin A, Kurilkin P, Ladygin V, Lalik R, Lang S, Lapidus K, Lebedev A, Lopes L, Lorenz M, Maier L, Mangiarotti A, Markert J, Metag V, Michel J, Müntz C, Münzer R, Naumann L, Palka M, Pechenov V, Pechenova O, Petousis V, Pietraszko J, Przygoda W, Ramstein B, Rehnisch L, Reshetin A, Rost A, Rustamov A, Sadovsky A, Salabura P, Scheib T, Schmidt-Sommerfeld K, Schuldes H, Sellheim P, Siebenson J, Silva L, Sobolev YG, Spataro S, Ströbele H, Stroth J, Strzempek P, Sturm C, Svoboda O, Tarantola A, Teilab K, Tlusty P, Traxler M, Tsertos H, Vasiliev T, Wagner V, Wendisch C, Wirth J, Wüstenfeld J, Yurevich S, Zanevsky Y. Measurement of the quasi free np→ npπ+π−and np→ ppπ−π0reactions at 1.25 GeV With HADES. EPJ Web of Conferences 2014. [DOI: 10.1051/epjconf/20148102009] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
47
|
Ramstein B, Adamczewski-Musch J, Arnold O, Atomssa E, Behnke C, Berger-Chen J, Biernat J, Blanco A, Blume C, Böhmer M, Bordalo P, Chernenko S, Deveaux C, Dybczak A, Epple E, Fabbietti L, Fateev O, Fonte P, Franco C, Friese J, Fröhlich I, Galatyuk T, Garzón JA, Gill K, Golubeva M, Guber F, Gumberidze M, Harabasz S, Hennino T, Hlavac S, Höhne C, Holzmann R, Ierusalimov A, Ivashkin A, Jurkovic M, Kämpfer B, Karavicheva T, Kardan K, Koenig I, Koenig W, Kolb BW, Korcyl G, Kornakov G, Kotte R, Krása A, Krebs E, Kuc H, Kugler A, Kunz T, Kurepin A, Kurilkin A, Kurilkin P, Ladygin V, Lalik R, Lapidus K, Lebedev A, Lopes L, Lorenz M, Mahmoud T, Maier L, Mangiarotti A, Markert J, Metag V, Michel J, Müntz C, Münzer R, Naumann L, Palka M, Parpottas Y, Pechenov V, Pechenova O, Petousis V, Pietraszko J, Przygoda W, Rehnisch L, Reshetin A, Rost A, Rustamov A, Sadovsky A, Salabura P, Scheib T, Schmidt-Sommerfeld K, Schuldes H, Sellheim P, Siebenson J, Silva L, Sobolev Y, Spataro S, Ströbele H, Stroth J, Strzempek P, Sturm C, Svoboda O, Tarantola A, Teilab K, Tlusty P, Traxler M, Tsertos H, Vasiliev T, Wagner V, Wendisch C, Wirth J, Wüstenfeld J, Zanevsky Y, Zumbruch P. HADES results in elementary reactions. EPJ Web of Conferences 2014. [DOI: 10.1051/epjconf/20148101003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
48
|
Pietraszko J, Agakishiev G, Behnke C, Belver D, Belyaev A, Berger-Chen J, Blanco A, Blume C, Böhmer M, Cabanelas P, Chernenko S, Dritsa C, Dybczak A, Epple E, Fabbietti L, Fateev O, Fonte P, Friese J, Fröhlich I, Galatyuk T, Garzón JA, Gill K, Golubeva M, González-Díaz D, Guber F, Gumberidze M, Harabasz S, Hennino T, Höhne C, Holzmann R, Huck P, Ierusalimov A, Ivashkin A, Jurkovic M, Kämpfer B, Karavicheva T, Koenig I, Koenig W, Kolb BW, Korcyl G, Kornakov G, Kotte R, Krása A, Krebs E, Krizek F, Kuc H, Kugler A, Kurepin A, Kurilkin A, Kurilkin P, Ladygin V, Lalik R, Lang S, Lapidus K, Lebedev A, Lopes L, Lorenz M, Maier L, Mangiarotti A, Markert J, Metag V, Michel J, Müntz C, Münzer R, Naumann L, Palka M, Parpottas Y, Pechenov V, Pechenova O, Przygoda W, Ramstein B, Rehnisch L, Reshetin A, Rustamov A, Sadovsky A, Salabura P, Scheib T, Schuldes H, Siebenson J, Sobolev Y, Spataro S, Ströbele H, Stroth J, Strzempek P, Sturm C, Svoboda O, Tarantola A, Teilab K, Tlusty P, Traxler M, Tsertos H, Vasiliev T, Wagner V, Weber M, Wendisch C, Wüstenfeld J, Yurevich S, Zanevsky Y. In-medium hadron properties measured with HADES. EPJ Web of Conferences 2014. [DOI: 10.1051/epjconf/20146604023] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
49
|
Lorenz M, Agakishiev G, Behnke C, Belver D, Belyaev A, Berger-Chen J, Blanco A, Blume C, Böhmer M, Cabanelas P, Chernenko S, Dritsa C, Dybczak A, Epple E, Fabbietti L, Fateev O, Fonte P, Friese J, Fröhlich I, Galatyuk T, Garzón JA, Gill K, Golubeva M, González-Díaz D, Guber F, Gumberidze M, Harabasz S, Hennino T, Höhne C, Holzmann R, Huck P, Ierusalimov A, Ivashkin A, Jurkovic M, Kämpfer B, Karavicheva T, Koenig I, Koenig W, Kolb BW, Korcyl G, Kornakov G, Kotte R, Krása A, Krebs E, Krizek F, Kuc H, Kugler A, Kurepin A, Kurilkin A, Kurilkin P, Ladygin V, Lalik R, Lang S, Lapidus K, Lebedev A, Lopes L, Maier L, Mangiarotti A, Markert J, Metag V, Michel J, Müntz C, Münzer R, Naumann L, Palka M, Parpottas Y, Pechenov V, Pechenova O, Pietraszko J, Przygoda W, Ramstein B, Rehnisch L, Reshetin A, Rustamov A, Sadovsky A, Salabura P, Scheib T, Schuldes H, Siebenson J, Sobolev Y, Spataro S, Ströbele H, Stroth J, Strzempek P, Sturm C, Svoboda O, Tarantola A, Teilab K, Tlusty P, Traxler M, Tsertos H, Vasiliev T, Wagner V, Weber M, Wendisch C, Wüstenfeld J, Yurevich S, Zanevsky Y. Low mass dielectrons radiated off cold nuclear matter measured with HADES. EPJ Web of Conferences 2014. [DOI: 10.1051/epjconf/20146609011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
50
|
Kahle LCS, Roussière T, Maier L, Herrera Delgado K, Wasserschaff G, Schunk SA, Deutschmann O. Correction to “Methane Dry Reforming at High Temperature and Elevated Pressure: Impact of Gas-Phase Reactions”. Ind Eng Chem Res 2013. [DOI: 10.1021/ie4028473] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|